1 2<!DOCTYPE html> 3<html prefix="og: http://ogp.me/ns#" xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"> 4<head> 5 <meta http-equiv="Content-Type" content="text/html; charset=utf-8" /> 6 <meta name="viewport" content="width=device-width, initial-scale=1"> 7 <title>Submissions - Journal of Clinical Practice</title> 8 9<meta property="og:title" content="Submissions"/> 10<meta property="og:description" content="Submissions - Journal of Clinical Practice" /> 11<meta property="og:type" content="website" /> 12 <meta property="og:url" content="http://clinpractice.ru/clinpractice/about/submissions" /> 13 <meta property="og:site_name" content="Journal of Clinical Practice" /> 14 <meta property="og:image" content="https://clinpractice.ru/public/journals/19/cover_issue_15593_en_US.jpg" /> 15 <meta property="og:image" content="https://clinpractice.ru/public/site/pageHeaderLogoImage_en_US.png" /> 16<meta property="og:locale" content="en_US" /> 17 18 <meta name="title" lang="en" xml:lang="en" content="Submissions" /> 19 <meta name="description" lang="en" xml:lang="en" content="Clinical practice | Peer-review medical journal" /> 20 <meta name="keywords" lang="en" xml:lang="en" content="медиÑина, клиниÑеÑкий ÑлÑÑай, ÑÑаÑÑÑ, жÑÑнал" /> 21 <meta name="generator" content="Open Journal Systems 2.4.9.2" /> 22 23 <link rel="stylesheet" href="https://clinpractice.ru/lib/pkp/styles/pkp.css" type="text/css" /> 24 <link rel="stylesheet" href="https://clinpractice.ru/lib/pkp/styles/common.css" type="text/css" /> 25 <link rel="stylesheet" href="https://clinpractice.ru/styles/common.css" type="text/css" /> 26 <link rel="stylesheet" href="https://clinpractice.ru/styles/compiled.css?v=101042025" type="text/css" /> 27 <link rel="stylesheet" href="https://clinpractice.ru/styles/fontawesome/fontawesome.css" type="text/css" /> 28 29 <!-- Base Jquery --> 30
30<script type="text/javascript" src="https://clinpractice.ru/js/jquery-1.11.0.min.js"></script>
30 31
31<script type="text/javascript" src="https://clinpractice.ru/js/jquery-migrate.min.js" ></script>
31 32
32<script type="text/javascript" src="https://clinpractice.ru/js/custom.js" ></script>
32 33 34 <!-- SimpleBox --> 35
35<script type="text/javascript" src="https://clinpractice.ru/js/simplebox/simplebox.js"></script>
35 36 <link rel="stylesheet" type="text/css" media="all" href="https://clinpractice.ru/js/simplebox/simplebox.css" /> 37 38
38<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/lib/jquery/jquery.min.js"></script>
38 39
39<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/lib/jquery/plugins/jqueryUi.min.js"></script>
39 40
40<script type="text/javascript" src="https://clinpractice.ru/js/endojournals/jquery.placeholder.min.js"> </script>
40 41
41<script type="text/javascript" src="https://clinpractice.ru/js/endojournals/jquery.cycle.all.min.js"> </script>
41 42
42<script type="text/javascript" src="https://clinpractice.ru/js/endojournals/jquery.color-2.1.0.min.js"></script>
42 43
43<script type="text/javascript" src="https://clinpractice.ru/js/endojournals/main.js"> </script>
43 44 45 46 47 <link rel="stylesheet" href="https://clinpractice.ru/styles/sidebar.css" type="text/css" /> <link rel="stylesheet" href="https://clinpractice.ru/styles/rightSidebar.css" type="text/css" /> 48 <link rel="stylesheet" href="https://clinpractice.ru/styles/sitestyle.css?v=1101042025" type="text/css" /> 49 <link rel="stylesheet" href="https://clinpractice.ru/styles/fonts.css?v=101042025" type="text/css" /> 50 <link rel="stylesheet" href="https://clinpractice.ru/styles/adaptive.css" type="text/css" /> 51
51<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/lib/jquery/plugins/validate/jquery.validate.js"></script>
51 52 53 <link rel="stylesheet" href="https://clinpractice.ru/public/site/sitestyle.css" type="text/css" /> 54 <link rel="stylesheet" href="https://clinpractice.ru/plugins/generic/pln/css/pln.css" type="text/css" /> 55 <link rel="stylesheet" href="https://clinpractice.ru/plugins/blocks/languageToggle/styles/languageToggle.css" type="text/css" /> 56 57 <!-- Default global locale keys for JavaScript --> 58
59<script type="text/javascript"> 60 jQuery.pkp = jQuery.pkp || { }; 61 jQuery.pkp.locale = { }; 62 63 jQuery.pkp.locale.form_dataHasChanged = 'The data on this form has changed. Continue anyway?'; 64 </script>
64 65 <!-- Compiled scripts --> 66
67<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/lib/jquery/plugins/jquery.tag-it.js"></script>
vendor: 1 bytes, line 67
67
68<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/lib/jquery/plugins/jquery.cookie.js"></script>
68 69
70<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/functions/fontController.js"></script>
vendor: 1 bytes, line 70
70
71<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/functions/general.js"></script>
vendor: 1 bytes, line 71
71
72<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/functions/jqueryValidatorI18n.js"></script>
vendor: 1 bytes, line 72
72
73<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/lib/underscore/underscore.js" type="text/javascript"></script>
73 74
75<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/classes/Helper.js"></script>
vendor: 1 bytes, line 75
75
76<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/classes/ObjectProxy.js"></script>
vendor: 1 bytes, line 76
76
77<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/classes/Handler.js"></script>
vendor: 1 bytes, line 77
77
78<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/classes/linkAction/LinkActionRequest.js"></script>
vendor: 1 bytes, line 78
78
79<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/classes/features/Feature.js"></script>
79 80
81<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/controllers/SiteHandler.js"></script>
81<!-- Included only for namespace definition -->
82<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/controllers/UrlInDivHandler.js"></script>
vendor: 1 bytes, line 82
82
83<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/controllers/AutocompleteHandler.js"></script>
vendor: 1 bytes, line 83
83
84<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/controllers/ExtrasOnDemandHandler.js"></script>
vendor: 1 bytes, line 84
84
85<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/controllers/form/FormHandler.js"></script>
vendor: 1 bytes, line 85
85
86<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/controllers/form/AjaxFormHandler.js"></script>
vendor: 1 bytes, line 86
86
87<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/controllers/form/ClientFormHandler.js"></script>
vendor: 1 bytes, line 87
87
88<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/controllers/grid/GridHandler.js"></script>
vendor: 1 bytes, line 88
88
89<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/controllers/linkAction/LinkActionHandler.js"></script>
vendor: 1 bytes, line 89
89
90<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/controllers/form/MultilingualInputHandler.js" type="text/javascript"></script>
90 91
92<script type="text/javascript" src="https://clinpractice.ru/js/pages/search/SearchFormHandler.js"></script>
vendor: 1 bytes, line 92
92
93<script type="text/javascript" src="https://clinpractice.ru/js/statistics/ReportGeneratorFormHandler.js"></script>
vendor: 1 bytes, line 93
93
94<script type="text/javascript" src="https://clinpractice.ru/plugins/generic/lucene/js/LuceneAutocompleteHandler.js"></script>
94 95
96<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/lib/jquery/plugins/jquery.pkp.js"></script>
vendor: 1 bytes, line 96
96
97<script type="text/javascript" src="https://clinpractice.ru/lib/pkp/js/classes/TinyMCEHelper.js"></script>
97 98 <!-- Form validation --> 99
99<script type="text/javascript"> 100 <!-- 101 // initialise plugins 102 103 $(function(){ 104 jqueryValidatorI18n("https://clinpractice.ru", "en_US"); // include the appropriate validation localization 105 106 $(".tagit").live('click', function() { 107 $(this).find('input').focus(); 108 }); 109 }); 110 // --> 111 112 </script>
112 113 114 115 116
116<script language="javascript" type="text/javascript" src="https://clinpractice.ru/lib/pkp/lib/tinymce/jscripts/tiny_mce/tinymce.min.js"></script>
116 117
117<script language="javascript" type="text/javascript"> 118 tinymce.init({ 119 selector : "textarea#referenceBody,textarea#emailBody,textarea#invoiceInstructions,textarea#blockContent,textarea#staticPageContent", 120 max_width: "100%", 121 height: 300, 122 resize: "both", 123 124 convert_urls: false, 125 forced_root_block : "p", 126 paste_auto_cleanup_on_paste : true, 127 apply_source_formatting : true, 128 plugins: [ 129 "code code advlist autolink anchor link image lists charmap hr", 130 "searchreplace wordcount visualblocks visualchars fullscreen media", 131 "table paste preview tiny_mce_wiris image mathjax latex insertCode" 132 ], 133 toolbar: "styleselect fontselect insert | removeformat | bold italic | subscript superscript | forecolor backcolor | copy cut paste searchreplace spellchecker | undo redo | alignleft aligncenter alignright alignjustify | bullist numlist outdent indent | link unlink anchor | table image media insertCode charmap | preview fullscreen code visualchars visualblocks | tiny_mce_wiris_formulaEditor tiny_mce_wiris_formulaEditorChemistry | mathjax latex", 134 toolbar_mode: "wrap", 135 a11y_advanced_options: true, 136 image_advtab: true, 137 branding: false, 138 draggable_modal: true, 139 browser_spellcheck: true, 140 spellchecker_rpc_url: "spellchecker.php", 141 spellchecker_languages: "English=en,Russian=ru", 142 contextmenu: false, 143 image_advtab: true, 144 statusbar: true, 145 menubar: false, 146 mathjax: { 147 lib: "https://clinpractice.ru/lib/pkp/lib/tinymce/jscripts/tiny_mce/plugins/mathjax/tex-mml-chtml.js", 148 className: "math" 149 }, 150 content_style: "@import url(/styles/fonts/izhitsa/izhitsa.css); @import url(/styles/fonts/flavius/flavius.css);", 151 font_formats: 152 "Andale Mono=andale mono,times; Arial=arial,helvetica,sans-serif; Arial Black=arial black,avant garde; Book Antiqua=book antiqua,palatino; Comic Sans MS=comic sans ms,sans-serif; Courier New=courier new,courier; Flavius=flavius; Georgia=georgia,palatino; Helvetica=helvetica; Impact=impact,chicago; Izhitsa=izhitsa; Oswald=oswald; Symbol=symbol; Tahoma=tahoma,arial,helvetica,sans-serif; Terminal=terminal,monaco; Times New Roman=times new roman,times; Trebuchet MS=trebuchet ms,geneva; Verdana=verdana,geneva; Webdings=webdings; Wingdings=wingdings,zapf dingbats", 153 }); 154 </script>
154 155 156 157
157<script> 158 MathJax = { 159 tex: { 160 inlineMath: [['$', '$'], ['\\(', '\\)']], 161 displayMath: [ 162 ['$$', '$$'], 163 ['\\[', '\\]'] 164 ], 165 }, 166 svg: { 167 fontCache: 'global' 168 } 169 }; 170 </script>
170 171 172
172<script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
172 173
173<script> 174 var categoryCount = 0; 175 </script>
175 176 177 <!-- Yandex.Metrika counter -->
178<script type="text/javascript"> 179 (function(m,e,t,r,i,k,a){ 180 m[i]=m[i]||function(){(m[i].a=m[i].a||[]).push(arguments)}; 181 m[i].l=1*new Date(); 182 for (var j = 0; j < document.scripts.length; j++) {if (document.scripts[j].src === r) { return; }} 183 k=e.createElement(t),a=e.getElementsByTagName(t)[0],k.async=1,k.src=r,a.parentNode.insertBefore(k,a) 184 })(window, document,'script','https://mc.yandex.ru/metrika/tag.js?id=63852682', 'ym'); 185 186 ym(63852682, 'init', {ssr:true, webvisor:true, clickmap:true, ecommerce:"dataLayer", referrer: document.referrer, url: location.href, accurateTrackBounce:true, trackLinks:true}); 187</script>
187 188<noscript><div><img src="https://mc.yandex.ru/watch/63852682" style="position:absolute; left:-9999px;" alt="" /></div></noscript> 189<!-- /Yandex.Metrika counter --> 190</head> 191<body id="pkp-about.submissions"> 192<div id="container"> 193 194 195<div id="header"> 196 <div id="headerWrap" class="headerWrap_en_US"> 197 <div id="languageToggle"> 198 <div class="active en_US"> 199 <img id="currentLanguageFlag" src="https://clinpractice.ru/plugins/blocks/languageToggle/locale/en_US/en_US.png" alt="English" title="English"/> 200 </div> 201 <div class="ru_RU"> 202 <a href='https://clinpractice.ru/clinpractice/user/setLocale/ru_RU?source=%2Fclinpractice%2Fabout%2Fsubmissions'> 203 <img src="https://clinpractice.ru/plugins/blocks/languageToggle/locale/ru_RU/ru_RU.png" alt="Ð ÑÑÑкий" title="Ð ÑÑÑкий"/> 204 </a> 205 </div> 206 </div> 207 208 <div id="siteLogo"> 209 <img src="https://clinpractice.ru/public/site/pageHeaderLogoImage_en_US.png" alt="Eco-vector" /> 210 </div> 211 212 <div id="headerTitle" class="headerTitle_en_US"> 213 <a href="https://clinpractice.ru/clinpractice/index"> 214 Journal of Clinical Practice 215 </a> 216 </div> 217 218 <div id="journalLogo"> 219 </div> 220 221 <div id="headerIssn"> 222 <span>ISSN 2220-3095 (Print)</span> 223 <span>ISSN 2618-8627 (Online)</span> 224 </div> 225 </div> 226</div> 227 228<section class="navbar"> 229 <div class="navbarDiv"> 230 <nav> 231 <div class="navMobile"> 232 <a id="navMobileLink" href="#!"><img id="menuHamburger" src="/img/style/menu_icon.png"><span>Menu</span></a> 233 <a href="https://clinpractice.ru/clinpractice/issue/archive">Archives</a> 234 </div> 235 <ul class="menu"> 236 <li id="home"><a href="https://clinpractice.ru/clinpractice/index">Home</a></li> 237 238 239 <li class="sep"></li> 240 <li class="navItem" id="navItem-about"><a href="#">About the Journal</a> 241 <ul class="dropdown"> 242 <li id="navSubItem-about-redaction"><a href="https://clinpractice.ru/clinpractice/about/editorialTeam">Editorial Team</a></li> 243 <li id="navSubItem-about-politics"><a href="https://clinpractice.ru/clinpractice/about/editorialPolicies">Editorial Policies</a></li> 244 <li id="navSubItem-about-forAuthors"><a href="https://clinpractice.ru/clinpractice/about/submissions">Author Guidelines</a></li> 245 <li id="navSubItem-about-forAuthors"><a href="https://clinpractice.ru/clinpractice/about">About the Journal</a></li> 246 </ul> 247 </li> 248 249 <li class="sep"></li> 250 <li class="navItem" id="navItem-content"><a href="#">Issues</a> 251 <ul class="dropdown"> 252 <li id="navSubItem-journal-search"><a href="https://clinpractice.ru/clinpractice/search">Search</a></li> 253 <li id="navSubItem-journal-current"><a href="https://clinpractice.ru/clinpractice/issue/current">Current</a></li> 254 <li id="navSubItem-journal-prePrints"><a href="https://clinpractice.ru/clinpractice/issue/prePrints">Articles in press</a></li> <li id="navSubItem-journal-retracted"><a href="https://clinpractice.ru/clinpractice/issue/retracted">Retracted articles</a></li> 255 <li id="navSubItem-journal-archives"><a href="https://clinpractice.ru/clinpractice/issue/archive">Archives</a></li> 256 </ul> 257 </li> 258 259 <li class="sep"></li> 260 <li class="navItem" id="navItem-contacts"><a href="https://clinpractice.ru/clinpractice/about/contact">Contact</a></li> 261 262 <li class="sep"></li> 263 <li class="navItem" id="navItem-subscriptions"><a href="https://clinpractice.ru/clinpractice/about/subscriptions">Subscriptions</a></li> 264 265 266 267 268 <li class="sep"></li> 269 <li class="navItem" id="navItem-journals"><a href="https://journals.eco-vector.com/index">All Journals</a></li> 270 271 </ul> 272 </nav> 273 </div> 274</section> 275<div id="body"> 276 277 <div id="sidebar"> 278 <div id="wideRightSidebarOpener"></div> 279 <div id="rightSidebar"> 280 <div class="block" id="submitManuscriptBlock"> 281 <a href="https://clinpractice.ru/clinpractice/author/submit"><img src="/img/style/submit_US.png"></a> 282</div>�<div class="block custom" id="customblock-SALE"> 283 284</div> <div class="block" id="sidebarUser"> 285 <span class="blockTitle">User</span> 286 287 <form method="post" action="https://clinpractice.ru/clinpractice/login/signIn"> 288 <table style="width:228px;"> 289 <tr style="width:228px;"> 290 <td colspan="2"><label for="sidebar-username">Username</label><input type="text" id="sidebar-username" name="username" value="" size="12" maxlength="32" class="textField" /></td> 291 </tr> 292 <tr> 293 <td colspan="2"><label for="sidebar-password">Password</label><input type="password" id="sidebar-password" name="password" value="" size="12" maxlength="32" class="textField" /></td> 294 </tr> 295 <tr> 296 <td colspan="2"><input type="checkbox" id="remember" name="remember" value="1" /> <label for="remember">Remember me</label></td> 297 </tr> 298 <tr style="width:228px;"> 299 <td colspan="2" align="center" style="vertical-align: middle; padding: 5px;"><input style="float: none;" type="submit" value="Login" class="button" /></td> 300 </tr> 301 <tr> 302 <td style="width: 114px; text-align:center; vertical-align:middle;"><a href="https://clinpractice.ru/clinpractice/login/lostPassword">Forgot password?</a></td> 303 <td style="width: 114px; text-align:center; vertical-align:middle;"><a href="https://clinpractice.ru/clinpractice/user/register" style="color: red">Register</a></td> 304 </tr> 305 </table> 306 </form> 307 </div><div class="block" id="notification"> 308 <span class="blockTitle">Notifications</span> 309 <ul> 310 <li><a href="https://clinpractice.ru/clinpractice/notification">View</a></li> 311 <li><a href="https://clinpractice.ru/clinpractice/notification/subscribeMailList">Subscribe</a></li> 312 </ul> 313</div> 314 315 316<div class="block" id="sidebarNavigation"> 317 <span class="blockTitle">Search</span> 318 319 320 321 <form id="simpleSearchForm" action="https://clinpractice.ru/clinpractice/search/search"> 322 <table id="simpleSearchInput"> 323 <tr> 324 <td> 325 <label for="simpleQuery">Search</label> 326 <input type="text" id="simpleQuery" name="simpleQuery" size="15" maxlength="255" value="" class="textField" /> 327 </td> 328 </tr> 329 <tr> 330 <td><label for="searchField"> 331 Search Scope 332 <br /> 333 <select id="searchField" name="searchField" size="1" class="selectMenu"> 334 <option label="All" value="query">All</option> 335<option label="Authors" value="author">Authors</option> 336<option label="Title" value="title">Title</option> 337<option label="Abstract" value="abstract">Abstract</option> 338<option label="Index terms" value="indexTerms">Index terms</option> 339<option label="Full Text" value="fullText">Full Text</option> 340 341 </select></label> 342 </td> 343 </tr> 344 <tr> 345 <td><input type="submit" value="Search" class="button" /></td> 346 </tr> 347 </table> 348 </form> 349 350 <span class="blockSubtitle">Browse</span> 351 <ul> 352 <li><a href="https://clinpractice.ru/clinpractice/issue/archive">By Issue</a></li> 353 <li><a href="https://clinpractice.ru/clinpractice/search/authors">By Author</a></li> 354 <li><a href="https://clinpractice.ru/clinpractice/search/titles">By Title</a></li> 355 <li id="linkBrowseBySections"><a href="https://clinpractice.ru/clinpractice/browseSearch/sections">By Sections</a></li><li id="linkBrowseByIdentifyTypes"><a href="https://clinpractice.ru/clinpractice/browseSearch/identifyTypes">By Identify Types</a></li> 356 <li><a href="https://journals.eco-vector.com/index">Other Journals</a></li> 357 <li><a href="https://journals.eco-vector.com/index/search/categories">Categories</a></li> </ul> 358 </div> 359<div class="block" id="sidebarKeywordCloud"> 360 <span class="blockTitle">Keywords</span> 361 362 <a href="https://clinpractice.ru/clinpractice/search?subject=COVID-19"><span style="font-size: 150%;">COVID-19</span></a> 363 364 <a href="https://clinpractice.ru/clinpractice/search?subject=SARS-CoV-2"><span style="font-size: 110.29411764706%;">SARS-CoV-2</span></a> 365 366 <a href="https://clinpractice.ru/clinpractice/search?subject=acute%20coronary%20syndrome"><span style="font-size: 98.529411764706%;">acute coronary syndrome</span></a> 367 368 <a href="https://clinpractice.ru/clinpractice/search?subject=atrial%20fibrillation"><span style="font-size: 110.29411764706%;">atrial fibrillation</span></a> 369 370 <a href="https://clinpractice.ru/clinpractice/search?subject=biomarkers"><span style="font-size: 98.529411764706%;">biomarkers</span></a> 371 372 <a href="https://clinpractice.ru/clinpractice/search?subject=case%20report"><span style="font-size: 101.47058823529%;">
372case report</span></a> 373 374 <a href="https://clinpractice.ru/clinpractice/search?subject=children"><span style="font-size: 95.588235294118%;">children</span></a> 375 376 <a href="https://clinpractice.ru/clinpractice/search?subject=clinical%20case"><span style="font-size: 142.64705882353%;">clinical case</span></a> 377 378 <a href="https://clinpractice.ru/clinpractice/search?subject=colorectal%20cancer"><span style="font-size: 98.529411764706%;">colorectal cancer</span></a> 379 380 <a href="https://clinpractice.ru/clinpractice/search?subject=computed%20tomography"><span style="font-size: 113.23529411765%;">computed tomography</span></a> 381 382 <a href="https://clinpractice.ru/clinpractice/search?subject=coronary%20heart%20disease"><span style="font-size: 98.529411764706%;">coronary heart disease</span></a> 383 384 <a href="https://clinpractice.ru/clinpractice/search?subject=coronavirus"><span style="font-size: 101.47058823529%;">coronavirus</span></a> 385 386 <a href="https://clinpractice.ru/clinpractice/search?subject=ischemic%20stroke"><span style="font-size: 110.29411764706%;">ischemic stroke</span></a> 387 388 <a href="https://clinpractice.ru/clinpractice/search?subject=magnetic%20resonance%20imaging"><span style="font-size: 113.23529411765%;">magnetic resonance imaging</span></a> 389 390 <a href="https://clinpractice.ru/clinpractice/search?subject=obesity"><span style="font-size: 98.529411764706%;">obesity</span></a> 391 392 <a href="https://clinpractice.ru/clinpractice/search?subject=quality%20of%20life"><span style="font-size: 101.47058823529%;">quality of life</span></a> 393 394 <a href="https://clinpractice.ru/clinpractice/search?subject=radiofrequency%20ablation"><span style="font-size: 98.529411764706%;">radiofrequency ablation</span></a> 395 396 <a href="https://clinpractice.ru/clinpractice/search?subject=rehabilitation"><span style="font-size: 119.11764705882%;">rehabilitation</span></a> 397 398 <a href="https://clinpractice.ru/clinpractice/search?subject=sudden%20cardiac%20death"><span style="font-size: 101.47058823529%;">sudden cardiac death</span></a> 399 400 <a href="https://clinpractice.ru/clinpractice/search?subject=surgical%20treatment"><span style="font-size: 98.529411764706%;">surgical treatment</span></a> 401 402 <a href="https://clinpractice.ru/clinpractice/search?subject=treatment"><span style="font-size: 107.35294117647%;">treatment</span></a> 403 </div><div class="block" id="sidebarInformation"> 404 <span class="blockTitle">Information</span> 405 <ul> 406 <li><a href="https://clinpractice.ru/clinpractice/information/readers">For Readers</a></li> <li><a href="https://clinpractice.ru/clinpractice/information/authors">For Authors</a></li> <li><a href="https://clinpractice.ru/clinpractice/information/librarians">For Librarians</a></li> </ul> 407</div> 408 409 </div> 410 <div id="rightModal" class="modal"> 411 <div class="modal-content"> 412 <span class="closeRight">×</span> 413 <div class="block" id="submitManuscriptBlock"> 414 <a href="https://clinpractice.ru/clinpractice/author/submit"><img src="/img/style/submit_US.png"></a> 415</div>�<div class="block custom" id="customblock-SALE"> 416 417</div> <div class="block" id="sidebarUser"> 418 <span class="blockTitle">User</span> 419 420 <form method="post" action="https://clinpractice.ru/clinpractice/login/signIn"> 421 <table style="width:228px;"> 422 <tr style="width:228px;"> 423 <td colspan="2"><label for="sidebar-username">Username</label><input type="text" id="sidebar-username" name="username" value="" size="12" maxlength="32" class="textField" /></td> 424 </tr> 425 <tr> 426 <td colspan="2"><label for="sidebar-password">Password</label><input type="password" id="sidebar-password" name="password" value="" size="12" maxlength="32" class="textField" /></td> 427 </tr> 428 <tr> 429 <td colspan="2"><input type="checkbox" id="remember" name="remember" value="1" /> <label for="remember">Remember me</label></td> 430 </tr> 431 <tr style="width:228px;"> 432 <td colspan="2" align="center" style="vertical-align: middle; padding: 5px;"><input style="float: none;" type="submit" value="Login" class="button" /></td> 433 </tr> 434 <tr> 435 <td style="width: 114px; text-align:center; vertical-align:middle;"><a href="https://clinpractice.ru/clinpractice/login/lostPassword">Forgot password?</a></td> 436 <td style="width: 114px; text-align:center; vertical-align:middle;"><a href="https://clinpractice.ru/clinpractice/user/register" style="color: red">Register</a></td> 437 </tr> 438 </table> 439 </form> 440 </div><div class="block" id="notification"> 441 <span class="blockTitle">Notifications</span> 442 <ul> 443 <li><a href="https://clinpractice.ru/clinpractice/notification">View</a></li> 444 <li><a href="https://clinpractice.ru/clinpractice/notification/subscribeMailList">Subscribe</a></li> 445 </ul> 446</div> 447 448 449<div class="block" id="sidebarNavigation"> 450 <span class="blockTitle">Search</span> 451 452 453 454 <form id="simpleSearchForm" action="https://clinpractice.ru/clinpractice/search/search"> 455 <table id="simpleSearchInput"> 456 <tr> 457 <td> 458 <label for="simpleQuery">Search</label> 459 <input type="text" id="simpleQuery" name="simpleQuery" size="15" maxlength="255" value="" class="textField" /> 460 </td> 461 </tr> 462 <tr> 463 <td><label for="searchField"> 464 Search Scope 465 <br /> 466 <select id="searchField" name="searchField" size="1" class="selectMenu"> 467 <option label="All" value="query">All</option> 468<option label="Authors" value="author">Authors</option> 469<option label="Title" value="title">Title</option> 470<option label="Abstract" value="abstract">Abstract</option> 471<option label="Index terms" value="indexTerms">Index terms</option> 472<option label="Full Text" value="fullText">Full Text</option> 473 474 </select></label> 475 </td> 476 </tr> 477 <tr> 478 <td><input type="submit" value="Search" class="button" /></td> 479 </tr> 480 </table> 481 </form> 482 483 <span class="blockSubtitle">Browse</span> 484 <ul> 485 <li><a href="https://clinpractice.ru/clinpractice/issue/archive">By Issue</a></li> 486 <li><a href="https://clinpractice.ru/clinpractice/search/authors">By Author</a></li> 487 <li><a href="https://clinpractice.ru/clinpractice/search/titles">By Title</a></li> 488 <li id="linkBrowseBySections"><a href="https://clinpractice.ru/clinpractice/browseSearch/sections">By Sections</a></li><li id="linkBrowseByIdentifyTypes"><a href="https://clinpractice.ru/clinpractice/browseSearch/identifyTypes">By Identify Types</a></li> 489 <li><a href="https://journals.eco-vector.com/index">Other Journals</a></li> 490 <li><a href="https://journals.eco-vector.com/index/search/categories">Categories</a></li> </ul> 491 </div> 492<div class="block" id="sidebarKeywordCloud"> 493 <span class="blockTitle">Keywords</span> 494 495 <a href="https://clinpractice.ru/clinpractice/search?subject=COVID-19"><span style="font-size: 150%;">COVID-19</span></a> 496 497 <a href="https://clinpractice.ru/clinpractice/search?subject=SARS-CoV-2"><span style="font-size: 110.29411764706%;">SARS-CoV-2</span></a> 498 499 <a href="https://clinpractice.ru/clinpractice/search?subject=acute%20coronary%20syndrome"><span style="font-size: 98.529411764706%;">acute coronary syndrome</span></a> 500 501 <a href="https://clinpractice.ru/clinpractice/search?subject=atrial%20fibrillation"><span style="font-size: 110.29411764706%;">atrial fibrillation</span></a> 502 503 <a href="https://clinpractice.ru/clinpractice/search?subject=biomarkers"><span style="font-size: 98.529411764706%;">biomarkers</span></a> 504 505 <a href="https://clinpractice.ru/clinpractice/search?subject=case%20report"><span style="font-size: 101.47058823529%;">
505case report</span></a> 506 507 <a href="https://clinpractice.ru/clinpractice/search?subject=children"><span style="font-size: 95.588235294118%;">children</span></a> 508 509 <a href="https://clinpractice.ru/clinpractice/search?subject=clinical%20case"><span style="font-size: 142.64705882353%;">clinical case</span></a> 510 511 <a href="https://clinpractice.ru/clinpractice/search?subject=colorectal%20cancer"><span style="font-size: 98.529411764706%;">colorectal cancer</span></a> 512 513 <a href="https://clinpractice.ru/clinpractice/search?subject=computed%20tomography"><span style="font-size: 113.23529411765%;">computed tomography</span></a> 514 515 <a href="https://clinpractice.ru/clinpractice/search?subject=coronary%20heart%20disease"><span style="font-size: 98.529411764706%;">coronary heart disease</span></a> 516 517 <a href="https://clinpractice.ru/clinpractice/search?subject=coronavirus"><span style="font-size: 101.47058823529%;">coronavirus</span></a> 518 519 <a href="https://clinpractice.ru/clinpractice/search?subject=ischemic%20stroke"><span style="font-size: 110.29411764706%;">ischemic stroke</span></a> 520 521 <a href="https://clinpractice.ru/clinpractice/search?subject=magnetic%20resonance%20imaging"><span style="font-size: 113.23529411765%;">magnetic resonance imaging</span></a> 522 523 <a href="https://clinpractice.ru/clinpractice/search?subject=obesity"><span style="font-size: 98.529411764706%;">obesity</span></a> 524 525 <a href="https://clinpractice.ru/clinpractice/search?subject=quality%20of%20life"><span style="font-size: 101.47058823529%;">quality of life</span></a> 526 527 <a href="https://clinpractice.ru/clinpractice/search?subject=radiofrequency%20ablation"><span style="font-size: 98.529411764706%;">radiofrequency ablation</span></a> 528 529 <a href="https://clinpractice.ru/clinpractice/search?subject=rehabilitation"><span style="font-size: 119.11764705882%;">rehabilitation</span></a> 530 531 <a href="https://clinpractice.ru/clinpractice/search?subject=sudden%20cardiac%20death"><span style="font-size: 101.47058823529%;">sudden cardiac death</span></a> 532 533 <a href="https://clinpractice.ru/clinpractice/search?subject=surgical%20treatment"><span style="font-size: 98.529411764706%;">surgical treatment</span></a> 534 535 <a href="https://clinpractice.ru/clinpractice/search?subject=treatment"><span style="font-size: 107.35294117647%;">treatment</span></a> 536 </div><div class="block" id="sidebarInformation"> 537 <span class="blockTitle">Information</span> 538 <ul> 539 <li><a href="https://clinpractice.ru/clinpractice/information/readers">For Readers</a></li> <li><a href="https://clinpractice.ru/clinpractice/information/authors">For Authors</a></li> <li><a href="https://clinpractice.ru/clinpractice/information/librarians">For Librarians</a></li> </ul> 540</div> 541 542 </div> 543 </div> 544 </div> 545 546<div id="main"> 547 548<div id="breadcrumb"> 549 <div id="closeRightSidebar"></div> <a href="https://clinpractice.ru/clinpractice/index">Home</a> > 550 <a href="https://clinpractice.ru/clinpractice/about" class="hierarchyLink">About the Journal</a> > 551 <a href="https://clinpractice.ru/clinpractice/about/submissions" class="current">Submissions</a></div> 552 553 554<div id="content"> 555 556 557<h1>Submissions</h1> 558 559 560<ul> 561 <li><a href="https://clinpractice.ru/clinpractice/about/submissions#onlineSubmissions">Online Submissions</a></li> 562 <li><a href="https://clinpractice.ru/clinpractice/about/submissions#authorGuidelines">Author Guidelines</a></li> <li><a href="https://clinpractice.ru/clinpractice/about/submissions#copyrightNotice">Copyright Notice</a></li> <li><a href="https://clinpractice.ru/clinpractice/about/submissions#privacyStatement">Privacy Statement</a></li> <li><a href="https://clinpractice.ru/clinpractice/about/submissions#authorFees">Author Fees</a></li> 563</ul> 564 565<div id="onlineSubmissions"> 566 <h2>Online Submissions</h2> 567 <p> 568 Already have a Username/Password for Journal of Clinical Practice?<br /> 569 <a href="https://clinpractice.ru/clinpractice/login" class="action">Go to Login</a> 570 </p> 571 <p> 572 Need a Username/Password?<br /> 573 <a href="https://clinpractice.ru/clinpractice/user/register" class="action">Go to Registration</a> 574 </p> 575 <p>Registration and login are required for submitting items online, and for checking the status of current submissions.</p> 576 </div> 577 578<div class="separator"> </div> 579 580<div id="authorGuidelines"><h2>Author Guidelines</h2> 581<p><p>Preparing the manuscript, authors are kindly requested to adhere to the following guidelines based on the <a href="https://www.icmje.org/recommendations/"><strong>Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals</strong></a> by the <a href="http://www.icmje.org/about.html">International Committee of Medical Journal Editors</a>.</p><p>The Editorial team emphasizes the need for strict adherence to the guidelines for manuscript formatting and submission. It may reject manuscripts if the authors fail to meet the requirements below.</p><p>The Editorial Office only considers original works for publication. The authors should only submit manuscripts that have not been previously published or submitted elsewhere.</p><p> </p><div><details><summary>I. Formal Procedures</summary><h3><br>Submission of Manuscripts and Files; Editorial Communication</h3><p>All manuscripts, supporting or supplementary materials, or revised versions should be submitted exclusively (!) via the Editorial Management System to the Editorial Office.</p><table><tbody><tr><td><p><strong>PLEASE NOTE:</strong> The Editorial Office only accepts manuscripts uploaded via the Editorial Management System on the journalâs official website. Manuscripts submitted via email or in any other way will be <strong>rejected</strong>. Do not submit any materials via email. Upload them to the Editorial Management System first.</p></td></tr></tbody></table><p><br>One of the authors should log in or sign up to the Editorial Management System on the journalâs website. All contributing authors are encouraged to sign up on the journalâs website.</p><p>The manuscript submission process involves several steps:</p><ul><li>Step 1. Select the appropriate journal section and the submission language. Next, carefully read through the Submission checklist. Check all the points to confirm them.</li><li>Step 2. Upload your full-text manuscript file.</li><li>Step 3. Upload all the supporting documents and supplementary files.</li><li>Step 4. Provide as much information as possible about each (!) author. Please list the authors in the correct order. All the authors should be listed at submission.</li><li>Step 5. Enter the relevant metadata in the designated fields: <em>Title, Abstract, Keywords, Funding Sources, </em>and<em> References</em>
581.</li><li>Step 6. Copy and paste your manuscript into the <em>Article Full Text</em> field.</li><li>Step 7. Carefully review the APC-related information, including mandatory and optional fees, payment terms, payment methods, and waiver policy.</li><li>Step 8. Click the <strong>Finish Submission</strong> button to finalize your submission. <em>The manuscript will not be submitted without this step.<br><br></em></li></ul><table><tbody><tr><td><p><strong>PLEASE NOTE:</strong> After you successfully submit your manuscript to the Editorial Office via the Editorial Management System, you will receive a confirmation email (!) to the email address specified in the senderâs profile. This letter confirms that the Editorial Office has received your manuscript. If you have not received the email, it means your manuscript submission is incomplete. Please return and finish it.</p></td></tr></tbody></table><p><strong> </strong></p><h3>Mandatory Supporting Documents</h3><p>Submissions should include a manuscript file and supplementary files:</p><ul><li><strong>Images</strong>, if any (upload each figure as a separate file);</li><li>A <strong>cover letter</strong> in a free format, signed by <strong>all </strong>the<strong> </strong>authors. Multiple identical letters containing all necessary signatures may be submitted (download the form).<br><br></li></ul><p>If the authors need to add any files during the editorial process, the corresponding author who submitted the article to the Editorial Office should:</p><ul><li>Log in to Editorial Management System on the journalâs website;</li><li>Open the <em>Author</em> section;</li><li>Click on the title of the corresponding manuscript;</li><li>Click the <em>Summary </em>tab (at the top of the page);</li><li>Use the <em>Add a Supplementary File</em> button to upload the file;</li><li>
581Enter the file title to describe the uploaded material.<br><br></li></ul><h3>Supplementary Files and Documents</h3><p>To provide a comprehensive description of the article subject, the author may include supplementary materials, such as audio and video files, slide decks, tables of source data, or figures. The author must be the copyright holder for such materials and have not transferred these rights to anyone else, except for the publisher. Otherwise, the author must obtain written permission from the copyright holder to use the materials for publication and dissemination in our journal.</p><p>Supplementary materials are published online only. The publisher creates a permanent direct links from the articleâs full text to any additional online files. The print version of the article will include a QR code and a link to each file, along with its name (e.g., âSupplement 1. Studies selected for meta-analysis. DOI: 10.17816/XXXXXXâ).</p><p>Supplementary materials are often published in their original form, as submitted by the author. This is especially true for large, complex tables, audio and video files, and slide decks.</p><p>Supplementary materials are part of the article and are subject to all the guidelines and requirements set by the publisher, as well as current legislation and copyright laws applicable to independent copyrighted items. The terms of the author agreement signed at manuscript submission also apply to all supplementary materials.</p><p> </p></details></div><div><details><summary>II. General Requirements for Manuscripts</summary><h3><br>Manuscript Language</h3><p>The journal only accepts manuscripts written in English. Citizens of Russia and the Commonwealth of Independent States may submit manuscripts in Russian.</p><h3>Manuscript Master File</h3><p>Accepted formats: *.doc, *.docx, or *.rtf. Files must be fully editable and unrestricted. Supplementary files and supporting documents may be uploaded in different formats.</p><h3>Full Manuscript Length</h3><ul><li>Original studies, reviews and study protocols should not exceed 6000 words, including tables, figures, author information, and references. Systematic reviews, meta-analyses can be even bigger.</li><li>The full-text length of case reports or short communications should not exceed 4000 words.</li><li>Correspondence and other non-research works should fall within 1500 words.</li><li>The Editorial Office may consider manuscripts that exceed the word limit, but only with prior approval.<br><br></li></ul><h3>Manuscript Formatting</h3><p>The manuscript, including text within tables and figures, should be typed in Times New Roman, 12 pt with 1.0 pt line spacing and 2 cm margins on all sides. Do not use hyphenation to break lines. For highlighting, use ONLY <em>italics</em> or <strong>bold</strong>, do not <u>underline</u>. Use the <em>Find and Replace</em> function to remove repeated spaces and extra line breaks. AVOID writing any text IN ALL CAPS, including your title, headings or subheadings.</p><h3>Manuscript File completing</h3><p>The file should include all information intended for publication, such as figures, tables, captions, and author information.</p><p> </p></details></div><div><details><summary>III. Manuscript Structure and Style Files</summary><h3><br>Types of Publications</h3><ul><li>Review</li><li>Systematic review</li><li>Meta-analysis</li><li>Original study</li><li>Brief communication</li><li>Study protocol</li><li>Case study<br><br></li></ul><p>The journal may publish other types of original works (e.g., datasets, databases, technical reports, book reviews, commentaries and replies, consensus papers, discussions, lectures, biographies, news items, interviews, historical articles, or practical guidelines) and editorial communications (e.g., editorials, retractions, partial retractions, corrections, corrigenda, additions to previously published articles, or expressions of concern). These are not subject to the requirements below.</p><p> </p><h3>Style Files</h3><p>The Editorial Office strongly recommends that authors adhere to the style file and recommendations therein. Each file briefly describes how to correctly present information in terms of sequence, format, and structure.</p><p>Please choose the <em>Editorial Word template </em>according to the type of your manuscript:</p><ul><li><a href="https://cloud.eco-vector.com/public.php/dav/files/TEgeaD2r3SLZRs7/?accept=zip"><strong> </strong><strong>Original study article</strong></a></li><li><a href="https://cloud.eco-vector.com/public.php/dav/files/aqp2g6AZAwzik7t/?accept=zip"><strong> </strong><strong>Review article</strong></a></li><li><a href="https://cloud.eco-vector.com/public.php/dav/files/JobgY4HMnTkZsJ5/?accept=zip"><strong> </strong><strong>Case report</strong></a><br><br></li></ul><h3>Article Structure</h3><p>Please follow the international guidelines for transparent and accurate reporting data in scholarly articles at the <a href="https://www.equator-network.org/"><strong>EQUATOR Network platform</strong></a> (<strong>E</strong>nhancing the <strong>QU</strong>ality <strong>A</strong>nd <strong>T</strong>ransparency <strong>o</strong>f health <strong>R</strong>esearch). The reporting guidelines for the main study types are:</p><ul><li>Observational studies (<a href="https://www.equator-network.org/reporting-guidelines/strobe/">STROBE</a> & <a href="https://www.equator-network.org/?post_type=eq_guidelines&eq_guidelines_study_design=0&eq_guidelines_clinical_specialty=0&eq_guidelines_report_section=0&s=+STROBE+extension&btn_submit=Search+Reporting+Guidelines">Extensions</a>)</li><li>
581Randomized trials (<a href="https://www.equator-network.org/reporting-guidelines/consort/">CONSORT</a> & <a href="https://www.equator-network.org/?post_type=eq_guidelines&eq_guidelines_study_design=0&eq_guidelines_clinical_specialty=0&eq_guidelines_report_section=0&s=+CONSORT+extension&btn_submit=Search+Reporting+Guidelines">Extensions</a>)</li><li>Study protocols (<a href="http://www.spirit-statement.org/wp-content/uploads/2013/08/SPIRIT-Checklist-download-8Jan13.doc">SPIRIT</a> & <a href="https://www.equator-network.org/reporting-guidelines/prisma-protocols/">PRISMA-P</a>)</li><li>Systematic reviews (<a href="https://www.equator-network.org/reporting-guidelines/prisma/">PRISMA</a> & <a href="https://www.equator-network.org/?post_type=eq_guidelines&eq_guidelines_study_design=0&eq_guidelines_clinical_specialty=0&eq_guidelines_report_section=0&s=PRISMA+extension&btn_submit=Search+Reporting+Guidelines">Extensions</a>)</li><li>Diagnostic/prognostic studies (<a href="https://www.equator-network.org/reporting-guidelines/stard/">STARD</a> & <a href="https://www.equator-network.org/reporting-guidelines/tripod-statement/">TRIPOD</a>)</li><li>Case reports (<a href="https://www.equator-network.org/reporting-guidelines/care/">CARE</a> & <a href="https://www.equator-network.org/?post_type=eq_guidelines&eq_guidelines_study_design=0&eq_guidelines_clinical_specialty=0&eq_guidelines_report_section=0&s=CARE+case+extension&btn_submit=Search+Reporting+Guidelines">Extensions</a>)</li><li>Practice guidelines (<a href="https://www.equator-network.org/reporting-guidelines/the-agree-reporting-checklist-a-tool-to-improve-reporting-of-clinical-practice-guidelines/">AGREE</a> & <a href="https://www.equator-network.org/reporting-guidelines/right-statement/">RIGHT</a>)</li><li>Qualitative research (<a href="https://www.equator-network.org/reporting-guidelines/srqr/">SRQR</a> & <a href="https://www.equator-network.org/reporting-guidelines/coreq/">COREQ</a>)</li><li>Animal pre-clinical studies (<a href="https://www.equator-network.org/reporting-guidelines/improving-bioscience-research-reporting-the-arrive-guidelines-for-reporting-animal-research/">ARRIVE</a>)</li><li>Quality improvement studies (<a href="https://www.equator-network.org/reporting-guidelines/squire/">SQUIRE</a> & <a href="https://www.equator-network.org/?post_type=eq_guidelines&eq_guidelines_study_design=0&eq_guidelines_clinical_specialty=0&eq_guidelines_report_section=0&s=SQUIRE+extension&btn_submit=Search+Reporting+Guidelines">Extensions</a>)</li><li>Economic evaluations (<a href="https://www.equator-network.org/reporting-guidelines/cheers/">CHEERS</a>)</li><li>Studies of diagnostic accuracy (<a href="https://www.equator-network.org/reporting-guidelines/stard/">STARD</a>)</li><li>Qualitative research studies (<a href="https://www.equator-network.org/reporting-guidelines/srqr/">SRQR</a> и <a href="https://www.equator-network.org/reporting-guidelines/coreq/">COREQ</a>)</li><li>Bioscience research using laboratory animals (<a href="https://www.equator-network.org/reporting-guidelines/improving-bioscience-research-reporting-the-arrive-guidelines-for-reporting-animal-research/">ARRIVE</a>)</li><li>Health estimates reporting (<a href="https://data.who.int/about/data/gather">GATHER</a>)</li><li>Anatomical quality assurance (<a href="https://onlinelibrary.wiley.com/doi/10.1002/ca.22800">AQUA</a>)</li><li>Genetic association studies (<a href="https://doi.org/10.1371/journal.pmed.1000022">STREGA</a>)<br><br></li></ul><p>Descriptions of statistical methods and results should comply with the <a href="https://www.equator-network.org/2013/02/11/sampl-guidelines-for-statistical-reporting/"><strong>SAMPL</strong></a> (Statistical Analyses and Methods in the Published Literature) guidelines.</p><p> </p></details></div><div><details><summary>IV. Referencing Guidelines</summary><p>Any statement made by the authors must be supported by references to their opinions (âin our opinion,â âwe believe,â etc.), personal experience (âunpublished dataâ), the opinions of others, or previous study results. The latter two must be supported by references to sources.</p><p>When a sentence or paragraph contains multiple statements, the references should be provided for each statement rather than placed at the end.</p><p>Each statement may be supported by references to no more than three (primary) sources. More sources should be justified, except for references in a systematic review.</p><p>References should prioritize primary sources, such as original studies, systematic reviews (if applicable), professional association guidelines, or consensus statements. Only if such sources are unavailable, the author may include references to opinions (including those in reviews), case studies, or scientific information sources that have not been peer-reviewed, such as preprints and press releases. The status of such sources should be explicitly indicated in the text.</p><p>Secondary sources (including reviews) should be used with caution; for example, when the original work is out of print, or unavailable through regular sources or in the original language. In this case, cite the original work in the text and add a reference to the secondary source to the reference list. Use the phrase âcited in/by...â to show that you have not read the original work.</p><p>
581Where applicable, specify the period covered by the sourceâs statements rather than the publication year. The latter may be irrelevant in the context of data interpretation.</p><p>Mention the names of the authors in the text (e.g., â[<em>1st authorâs last name</em>] et al.â) only when such mentions provide essential context beyond the reported results. Otherwise, do not mention the names of authors in the text.</p><p>Place each source on a new line under its corresponding serial number <strong>in the reference list</strong>. For more information, see the <a href="https://journals.eco-vector.com/index/pages/view/references_split"><strong>Reference Formatting</strong></a> section. Below are the key requirements:</p><ul><li>The list of primary sources should be arranged in the same order as they are cited throughout the text.</li><li>The number of cited works is unlimited; however, we recommend citing only the most relevant works.</li><li>In the text, cite your sources using Arabic numerals in square brackets (e.g., [1, 2]).</li><li>ALL AUTHORS must be listed in the bibliographic record for each source. For publications with more than four authors, use the abbreviation â... et al.â after the third author. Do not shorten the title of the article. Journal titles must be abbreviated according to the <a href="http://www.ncbi.nlm.nih.gov/nlmcatalog/journals/">NLM Catalog</a> (MEDLINE). If the journal is not indexed in MEDLINE, the full title must be provided. Do not abbreviate the titles of Russian journals.<br><br></li></ul><p>The reference list should comply with AMA style (<a href="http://www.amamanualofstyle.com/">http://www.amamanualofstyle.com</a>).</p><p> </p></details></div><div><details><summary>V. Use of Artificial Intelligence</summary><p>In accordance with <u>its editorial policy, </u>the journalâs editorial board does not restrict authors use of AI as a tool (method) for scientific research. However, as with other research methods, <em>authors must </em>disclose information regarding the use of AI by describing the tool (software, service, platform), its version, developer, source (the general URL of the service, where applicable), the procedure for its use, the queries (specifying the sequence and other details of their application) and the dates on which they were made (where applicable), as well as the results of checks on the accuracy and reliability of the results obtained using AI. This description must be presented in the METHODS section (or in another section of the manuscript suitable for describing the research methodology). The description of the use of AI as a research tool (method) must be sufficiently detailed to enable interested independent researchers to replicate the described approach if necessary.</p><p>The journalâs editorial team does not object to the use of AI in the preparation of a manuscript <em>for auxiliary purposes </em>(for example, to improve the style and readability of the text, for translation, for formatting the reference list, or for editing illustrative material). However, <em>authors must </em>declare such use of AI when initially submitting their work to the journal and (where applicable) at any stage of its review and editorial preparation. Information regarding the use of AI must be disclosed in the Additional Information section, under the heading Generative Artificial Intelligence (located at the end of the manuscript before the reference list) or in any other section intended for authors to declare the use of AI in the preparation of the manuscript. <em>Authors must </em>state the purposes of its use, identify the sections or components of the manuscript or other materials edited using AI, and specify the tool (software, service or platform, including the URL), its version, the developer, and the dates of use (where applicable). <em>This information is published </em>alongside the manuscript.</p><p>The journalâs editorial board strongly <em>advises against </em>using AI for translation without subsequent verification of the translations quality by a professional translator.</p><p><em>Authors must not </em>use AI <em>to create </em>the initial versions of materials submitted to the editorial board for consideration. The editorial board reserves the right to request source materials (e.g. a draft manuscript) for editorial assessment of the authors contribution and to make an informed decision on whether to proceed with the review of the work.</p><p><em>Authors must not </em>list AI as an (co-)author, nor must they refer to AI as an author or cite it (by borrowing text or images) in that capacity.</p><p>By submitting a manuscript or any other materials to the journals online editorial office, authors thereby confirm their agreement with all the provisions of the journalâs editorial policy and the Guidelines for Authors regarding the use of AI. In particular, authors should be aware that the materials they submit may be checked using both the publishers own and third-party software products (services) based on AI or designed to detect AI.</p><p><strong> </strong></p></details></div><div><details><summary>VI. Manuscript Elements</summary><div style="padding-left: 20px;"><div><details><summary><em>Formulas</em></summary><p>Mathematical formulas should be presented on separate lines using ONLY MathType (you may download MathType for Windows <a href="https://store.wiris.com/en/products/mathtype/download/windows"><strong>here</strong></a>).</p><table><tbody><tr><td><p><strong>PLEASE NOTE:</strong></p><ul><li>Do not use plug-ins or add-ons with similar names for office applications (e.g., MathType Add-In for Microsoft 365 or MathType Add-On for Google Worksp
581ace).</li><li>Do not use any built-in MS WORD tools (e.g., Equation Editor) to process formulas.</li><li><strong>Do not use MathType to typeset notations with only a superscript or subscript, units of measure, numbers in text, or simple mathematical or chemical formulas<br>(e.g., a<sup>2</sup> + 2ab + b<sup>2</sup> = (a + b)<sup>2</sup>; СH<sub>3</sub>СH<sub>2</sub>OH).</strong></li><li>In formulas, use italics for Latin characters and upright font for Greek characters (MathType > Style > Define).</li></ul></td></tr></tbody></table><p> </p></details></div><div><details><summary><em>Statistical Analysis</em></summary><p>The journal requires the use of appropriate statistical methods for publication. The statistical procedure must be described in the Methods section. A comprehensive list of all statistical methods and null hypothesis testing criteria must be provided. Accurate descriptions and applications of statistical analyses can substantially improve the reliability of the findings and their potential for use in future studies. Do not use vague statements such as âstandard statistical methods were used.â Provide details about the applied methods, tests, and parameters. Avoid common misconceptions about <em>p</em>-values, such as the âprobability of the null hypothesis,â the âprobability that the observed difference is due to chance,â or the âprobability of rejecting the null hypothesis.â</p><p>We recommend that authors collaborate with professional statisticians for studies involving more than two paired comparisons. Specify the level of significance (<em>p</em>-value) used in this study (e.g., âThe critical level of significance used to test statistical hypotheses in this study was <em>p</em> < 0.005â). The exact <em>p</em>-value for each statistical test should be provided, such as â<em>p</em> = 0.015â or â<em>p</em> = 0.267,â rather than â<em>p</em> < 0.05â or â<em>p</em> > 0.05.â</p><p>The exact values of the statistical tests should be specified (e.g., the Pearson chi-squared test is Ï<sup>2</sup> = 12.3 (df = 2, <em>p</em> = 0.0001). Avoid the vague use of terms with multiple meanings. For example, there are several types of correlation coefficients: Pearson coefficient, Spearman coefficient, etc.</p><p>All statistical terms, abbreviations, and symbols must be defined (e.g., M, mean; m, standard error of the mean; SD, standard deviation; <em>p</em>, significance level).</p><p>If the statistical tests and parameters are limited in use, explain how these limitations were tested and what the results were. For example, for parametric methods, specify which normality test was used for the sample distribution (e.g., KolmogorovâSmirnov, ShapiroâWilk, AndersonâDarling, or DâAgostinoâPearson tests). Define all symbols and include the sample size (<em>n</em>) for expressions such as M ± m.</p><p>Note that parameters M ± m and M ± SD can only be used to describe the quantitative characteristics of a group when the data are normally distributed.</p><p>Use a parametric Studentâs <em>t</em>-test only after testing for equality of variances. If they are not equal, use the Welchâs <em>t</em>-test instead. For an analysis of variance, specify which test was used to check for equality of variances: Fisherâs exact test, Cochranâs Q test, Bartlettâs test, Leveneâs test, or Dunnâs test.</p><p>When three or more groups are being compared, specify the procedure used to adjust for multiple comparisons.</p><p>For risk assessment, clearly distinguish between odds ratios, risk ratios, relative risks, and absolute risks.</p><p>Specify the name of the statistical package used for data analysis, e.g., BMDP, STATGRAPHICS, MINITAB, MEDCALC, SYSSTAT, STATISTICA, SPSS, R, CSS, STADIA, EVRISTA, SANI, BIOSTAT, MESOSAUR, DATASCOPE, STATA, SAS, EPIINFO, SOFA, MS EXCEL, S-PLUS, MSL-C, STAT-MEDIA, NCSS, JMP, etc. Please also indicate the version number (e.g., SYSSTAT 5.0.6), developer, and country.</p><p>Example: <em>STATISTICA v.13 (StatSoft, USA)</em> was used for data analysis.</p><p>For more details on the requirements for statistical presentation, see the <a href="https://www.equator-network.org/2013/02/11/sampl-guidelines-for-statistical-reporting/"><strong>SAMPL</strong></a> (Statistical Analyses and Methods in the Published Literature) guidelines.</p><p> </p></details></div><div><details><summary><em>Taxonomic Nomenclature</em></summary><p>The manuscript must use the generally accepted name for a study object, as established by taxonomic nomenclature. Latin genus and species names should be italicized (e.g., <em>Homo sapiens</em>), whereas higher-rank taxa should be set in upright font (e.g., Vertebrata or Metazoa). At the first mention, a genus or species name should be spelled out in full (e.g., <em>Escherichia coli</em>
581). Subsequent references should abbreviate the genus name, but not the species name (e.g., <em>E. coli</em>).</p><p>Taxonomic authorities should only be cited once: either when a taxon is first mentioned in the text or in designated lists if applicable. Do not italicize Syntaxon names.</p><p>Latin animal names must adhere to the <a href="https://journals.eco-vector.com/files/journals/9/supfiles/Code_Russian-Edition-2004_0.pdf">International Code of Zoological Nomenclature (ICZN)</a>. Plant names and authorities must follow the standards adopted by the<a href="https://www.ipni.org/"> International Plant Names Index (IPNI) </a>or <a href="http://www.theplantlist.org/">The Plant List</a>. Herbarium acronyms should follow <a href="http://sweetgum.nybg.org/science/ih/">Index Herbariorum</a>.</p><p>The nomenclature for genetic variants varies by organism. Please verify the correct notation in the appropriate databases.</p><p> </p></details></div><div><details><summary><em>Genetic Nomenclature</em></summary><p>Authors must verify gene and product names in relevant databases and use current, standardized symbols because genetic nomenclature varies among species. For gene and product names, see <a href="https://www.genenames.org/about/guidelines/">here</a> and <a href="https://www.uniprot.org/">here</a>.</p><p>Avoid using terms such as <em>polymorphism</em> or <em>mutation</em> for reference nucleotide variants differing from the reference nucleotide sequence. Use neutral terminology instead, such as <em>variant</em> or <em>substitution</em> (single nucleotide variant, SNV).</p><p>The first time a gene is mentioned in the text (outside the abstract), a footnote describing the gene in the relevant database should be included. Example: <em>HLA-DRB1 </em><a href="https://omim.org/entry/142857?search=HLA-DRB1&highlight=hla"><sup>[1]</sup></a><em>.</em></p><p>Use italics for gene symbols, genotypes, messenger ribonucleic acid (mRNA), complementary DNA (cDNA), and mobile genetic elements. Do not italicize full gene names, protein products, and phenotype descriptions. Do not use Greek letters, Roman numerals, dashes, hyphens, superscripts, or subscripts for the gene symbol, unless they are being used to designate a gene product or phenotype.</p><p> </p><p>Example:</p><table><tbody><tr><td><p>Gene</p></td><td><p>Poly(ADP-Ribose) Polymerase 1</p></td></tr><tr><td><p>Gene symbol</p></td><td><p><em>PARP1</em></p></td></tr><tr><td><p>Protein</p></td><td><p>PARP1</p></td></tr><tr><td><p>Genotype</p></td><td><p><em>PARP1<sup>+/-</sup></em></p></td></tr><tr><td><p>Phenotype</p></td><td><p>PARP1<sup>+</sup></p></td></tr><tr><td><p>mRNA</p></td><td><p>mRNA <em>PARP1</em></p></td></tr><tr><td><p>cDNA</p></td><td><p>cDNA <em>PARP1</em></p></td></tr><tr><td><p>Mobile element</p></td><td><p><em>TY</em></p></td></tr></tbody></table><p> </p><p>Gene symbols may be written in uppercase or lowercase, depending on species-specific nomenclature rules.</p><p> </p><p>Example:</p><table><tbody><tr><td><p><strong>Species</strong></p></td><td><p><strong>Gene (symbol)</strong></p></td><td><p><strong>Protein</strong></p></td></tr><tr><td><p><em>Escherichia coli</em></p></td><td><p><em>rdgB</em></p></td><td><p>RdgB</p></td></tr><tr><td><p><em>Saccharomyces cerevisiae</em></p></td><td><p><em>ADE2</em></p></td><td><p>Ade2</p></td></tr><tr><td><p><em>Homo sapiens</em></p></td><td><p><em>POLD1</em></p></td><td><p>Pol δ</p></td></tr><tr><td><p><em>Mus musculus</em></p></td><td><p>Tnfa</p></td><td><p>TNF-α</p></td></tr></tbody></table><p> </p><p>Human genomic variants should be described in accordance with the Human Genome Variation Society (HGVS) nomenclature.</p><p> </p><p>Example:</p><table><tbody><tr><td><p>Gene</p></td><td><p>Tumor protein p53</p></td></tr><tr><td><p>Symbol</p></td><td><p><em>TP53</em></p></td></tr><tr><td><p>Gene Nomenclature Committee ID</p></td><td><p>HGNC:11998</p></td></tr><tr><td><p>Genotype variants</p></td><td> </td></tr><tr><td><p>Position of cDNA substitution</p></td><td><p><em>TP53: </em>c.488A>G</p></td></tr><tr><td><p>Genomic position (including the reference sequence)</p></td><td><p><em>TP53: </em>g.7578442T>C (GRCh37.p13 chr 17 NC_000017.10)</p></td></tr><tr><td><p>Position of protein substitution</p></td><td><p>p.Tyr163Cys</p></td></tr><tr><td><p>Cis-heterozygosity</p></td><td><p>g.[7578442T>C;7577129A>C]</p></td></tr><tr><td><p>Trans-heterozygosity</p></td><td><p>g.[7578442T>C];[7577129A>C]</p></td></tr><tr><td><p>Heterozygote with unknown allelic configuration</p></td><td><p>g.[7578442T>C](;)[7577129A>C]</p></td></tr></tbody></table><p> </p><p>The nomenclature for genetic variants varies by organism. Please verify the correct notation in the corresponding databases.</p><p>The first time a gene is mentioned in the text (outside the abstract), a footnote describing the gene in the relevant database should be included.</p><p>Example: HLA-DRB1 (<a href="https://omim.org/entry/142857?search=HLA-DRB1&highlight=hla">
581https://omim.org/entry/142857?search=HLA-DRB1&highlight=hla</a>).</p><p> </p></details></div><div><details><summary><em>Abbreviations</em></summary><p>All abbreviations and symbols, including those in common use, should be defined at first mention in the text. Do not abbreviate terms in article titles, abstracts, section headings, tables, or figure captions.</p><p> </p></details></div><div><details><summary><em>Tables</em></summary><p>Place tables in the Tables section at the end of the article. Each table should have a numbered header and clearly marked columns to make it easier to read. The table data must align with the text. However, publication rules prohibit duplicating table data in the manuscript text. Each table must be referenced by a number in the article text.</p><p>All tables in the article must be numbered consecutively. A single table should also be numbered. Avoid abbreviations (except for commonly used ones) in the table header.</p><p>We recommend moving tables with more than four columns and a height exceeding one page to a Supplement. In this case, the text should reference the Supplement and not the table.</p><p>Any explanations of abbreviations and symbols used in the table should be placed in the Note below the table. For tables and their descriptions, make sure the main content is clear and does not require referencing to the manuscript text.</p><p> </p><p>Example of a table header:</p><p><strong>Table 2</strong>. Clinical and pathological characteristics of patients</p><p>How to reference it in the text:</p><p>Table 2 shows the clinical and pathological characteristics of the patients.</p><p> </p></details></div><div><details><summary><em>Figures</em></summary><p>A figure (image) is a visual representation of an object (diagram, drawing, picture, photo, map, etc.), numerical values (line, plane, or geometric figures), formulas (nomogram), processes, or phenomena (graph, flow charts).</p><p>Graphs and diagrams should be created using vector graphics editors, such as Adobe Illustrator, Corel Draw, or text editors (e.g., MS Word, MS Excel, MS PowerPoint). For vector graphics, all used fonts must be embedded in the file. To do this, select the Embed Fonts option when saving the file.</p><p>Figures should not have any gray (colored) background or grid. Please pay special attention to the colors used in figures, including those in simple line charts (see more information <a href="https://www.researchgate.net/publication/313657827_The_Information_Visualization_Thematic_Head_to_Head_with_Color_Blindness">here</a>).</p><p>Only image <strong>files </strong>(!) uploaded as supplementary materials via the Editorial Management System will be used for publication.</p><p> </p><p><strong>Figure Location</strong></p><p>Place each figure on a separate page at the end of the manuscript file.</p><p>All figures must be cited in the text in parentheses using the abbreviation âFig.â followed by the figure number.</p><p>Example: (Fig. 1).</p><p> </p><p>Images within multi-panel figures should be denoted by <em>lowercase Latin letters</em> in the text.</p><p>Example: (Fig. 2<em>b</em>).</p><p> </p><p>All <strong>graphs, diagrams, charts, drawings, </strong>and other figures created using MS Office or other text editors, as well as all <strong>photos </strong>(including screenshots), must be high-contrast and clear. The number of figures should be kept to a minimum unless it is necessary for the type of your work.</p><p>Example: </p><p><strong>Fig. 1.</strong> Study protocol.</p><p> </p><p><strong>Photos, screenshots, </strong>and other <strong>raster (NON-vector) images </strong>must also be uploaded separately in the designated section of the submission form. Accepted formats include *.tiff, *.eps, *.jpeg, *.bmp, and *.gif. Use *.doc or *.docx for annotated images only. Use <strong>Calibri </strong>font for all text within figures. The image resolution must be >300 dpi. Vector images should be submitted in files with the following extensions: *.ai, *.eps, or *.cdr. Each file name must contain the figure number in the manuscript. Each uploaded file should be accompanied by a caption identical to the figure title used in the text. </p><p>Example:</p><p><strong>Fig. 1.</strong> Ivan Sechenov.</p><p> </p><p><strong>Caption</strong></p><p>Each figure should have a caption that includes the following: 1) the symbol and serial number; 2) title; 3) legend; 4) note; and 5) information about a copyrighted item. Explanations for points 3â5 should be provided as required.</p><p><em>1) Figure designation and numbering. </em>All illustrations must be designated as figures. All figures must be numbered, even if only one is provided. Figures must be numbered consecutively throughout the manuscript (e.g., 1, 2, 3).</p><p><em>2) Figure titles</em> should be concise and descriptive. For multi-panel figures, the main title should include designations for each image. For more details, see the Legend section. Avoid abbreviations in figure titles (even those defined in the main text). Alternatively, define them in the figure legend.</p><p><em>3) A legend</em> explains symbols (such as letters, numbers, and graphic signs) <em>or </em>unmarked details in a figure.</p><ul><li>Use Latin letters to label multi-panel figures, and digital or graphic indicators for figure elements.</li><li>All symbols in the figure should be explained after the main title. First, explain the symbols in images of a multi-panel figure. Then, explain the symbols within the figure elements.</li><li>For a multi-panel figure with separate numbering for each image, first explain the details of the first image, then the details of the second one, and so on.</li><li>For any unlabeled elements, explain then below the legend.</li></ul><p><em>4) Note. </em>A note is used to clarify a figure title and legend.</p><ul><li>A note is required to make the image understandable without referring to the main text. This part of the caption should include measurement methods, imaging techniques and scale, and other details for evaluating the figure as a whole without reference to the main text.</li><li>The note must end with a definition of all abbreviations used in the title, legend, or image.</li><li>Do not use the Note term in the caption!</li></ul><p><em>5) Information about a copyrighted item. </em>The manuscript may present original images (created and owned by the authors, previously unpublished elsewhere) and third-party images (from previously published or unpublished sources).</p><p> </p><table><tbody><tr><td><p><strong>PLEASE NOTE: </strong>Images from unknown sources (including those intentionally anonymized) are not accepted for publication.</p><ul><li>Captions for <strong>original images</strong> should not include information about the authors or copyright holders. If the work is published, this information will appear on the title page of the article and will apply to all content, including the original images. Figure captions should end with a title and, where applicable, a legend or note.</li><li><strong>For third-party images</strong>, information about a copyright holder and authors should be included in the caption.<br /> 582<ul><li>Use the statement <em>âReproduced with the copyright holderâs permissionâ</em> if:</li><ul><li>The copyright holder (including a patient or their legal representative) retains all rights to previously published or unpublished third-party images. The authors of the manuscript must obtain permission from the copyright holder to publish the image in any media (including electronic versions) and to translate or modify the text elements, if any;</li><li>A third-party image is used under conditions that are different from those specified in the open license. In this case, the manuscript authors must obtain permission from the copyright holder to use the image under the new conditions.</li></ul><li>Use the statement â<em>Distributed under the license CCâ¦</em>â if a previously published or unpublished third-party image is used under the conditions of an open license (e.g., <a href="https://creativecommons.org/licenses/by/4.0/deed.ru">CC-BY</a>).</li></ul><ul><li><strong><em>For a third-party image</em></strong> <strong>used</strong> <strong>as is</strong>, use the statement âSource: Reproduced from...â and provide a numbered reference to the image source (â...[reference]â) or a URL if the figure is posted online.</li><li><strong><em>If you use a third-party image</em></strong> <strong><em>with translated text elements,</em></strong> use the statement âSource: Adapted from [reference] (<em>or</em> URL).â For original images with substantial modifications, use the statement: âSource: Reproduced/Adapted with modifications from [reference] (<em>or </em>URL).â This includes patient photographs obtained from the patient or his/her legal representatives where certain details have been obscured by the authors<a name="_ftnref4"></a>.</li><li><strong><em>For previously unpublished third-party images, </em></strong>use the statement âSource: Personal/family archive,â âArchive of [Institution],â or âArchive of [Department of Institution].â</li></ul></li><ul><li>For previously published third-party images (including those previously published by the same authors) or previously unpublished third-party original images (e.g., from institutional, family, or personal archives), <strong><em>three statements</em></strong> must be included in the figure caption: 1) a copyright statement; 2) terms of use for the copyrighted item; and 3) a summary of any modifications made to the original image.</li><li>Always (!) specify sources for third-party images.</li><li>The copyright statement must include: <strong><em>the copyright symbol </em></strong>(©); <strong><em>the name of the copyright holder</em></strong> (<strong><em>for a group of individuals</em></strong> (co-authors), use the first authorâs surname followed by âet al.â; <strong><em>for legal entities</em></strong>, use the short official name of the organization (omitting the legal form and departmental affiliation); <strong><em>if the holderâs identity is withheld for legal reasons</em></strong>, specify the source (e.g., âfamily/personal archive of the patient or their legal representativeâ); <strong><em>the year of publication</em></strong>.</li><li>Specify the terms of use for an original image as stipulated by the copyright holder:</li><li>At the end of this part of the caption:</li></ul></ul><p> Examples:</p><ul><li><strong>Fig. Ð¥</strong>. Title. Figure caption... From the family archive of the patient, previously unpublished. Reproduced with permission from the parent.</li><li><strong>Fig. Ð¥</strong>. Title. Figure caption... From the archive of [<em>Organization</em>], previously unpublished. Reproduced with permission from the administration of the institution.</li><li><strong>Fig. Ð¥</strong>. Title. Figure caption⦠The chart is reproduced from [<em>reference</em>]. © 2022 BMJ Publishing Group Ltd. All rights reserved.</li><li><strong>Fig. Ð¥</strong>. Title. Figure caption⦠The
582nomogram is adapted from [<em>reference</em>]. © 2022 BMJ Publishing Group Limited. Distributed under the license <a href="https://creativecommons.org/licenses/by/4.0/deed.ru">CC-BY</a>.</li><li><strong>Fig. Ð¥</strong>. Title. Figure caption⦠The figure is adapted from [<em>reference</em>]. © 2014 Ivanov et al. Distributed under the license <a href="https://creativecommons.org/licenses/by-nd-sa/4.0/">CC BY-ND-SA 4.0</a>.</li></ul></td></tr></tbody></table><p> </p></details></div><div><details><summary><em>Ethics Compliance Information</em></summary><p>The publisher and the Editorial Office adhere to strict publication ethics standards and do not permit the publication of works that directly or indirectly violate these principles.</p><p>Authors should include relevant information in their manuscripts to assure the editorial staff and readers that their work adheres to all applicable international publication ethics standards (and biomedical ethics standards for biology and medical journals).</p><p>Much of the information confirming ethical compliance may be included in the Additional Information section (please refer to the article template for formatting guidelines). Below is the structure of this section, with explanations provided for each section.</p><p>The Publisherâs Code of Ethics and the publication ethics standards followed by the editorial staff may be found on the respective pages:</p><ul><li><a href="https://eco-vector.com/Eco-Vector_Ethic_Policy.php">Publisherâs Code of Ethics</a></li><li>Editorial Policy.</li></ul><p> </p><h3>Additional Information</h3><p>The Additional Information section of the manuscript (see editorial templates) asks authors to provide information that may influence the opinions and decisions of editors, readers, researchers, and other stakeholders. Present the required information as brief statements that contain the most relevant details. Authors must provide information for every item in this section. The Acknowledgments, Consent for publication, and Disclaimer statements should only be added if applicable.</p><p> </p><table><tbody><tr><td><p><strong>PLEASE NOTE:</strong> The journal reserves the right to discontinue the review process or retract the published article if the authors are found to have intentionally submitted inaccurate information. The editorial staff and the publisher may terminate the editorial process without prior consultation with the Editorial Board and editor-in-chief. In case of retraction of a published article, an editorial investigation is initiated. Based on such investigation, the editor-in-chief decides whether the article should be retracted. The editorial staff reserves the right to notify any institutions mentioned in the manuscript about any major violations of research or publication ethics. For more details, see the <u>Editorial Policy</u>.</p></td></tr></tbody></table><p> </p></details></div><div><details><summary><em>Author Statements</em></summary><div style="padding-left: 40px;"><div><details><summary><small>1) Author contributions</small></summary><p>A research is a complex activity that usually involves multiple parties with different roles and levels of involvement in the research process. The roles of researchers must be clearly defined so that their contributions can be evaluated fairly, their responsibilities be determined, and disputes over authorship or unfair publishing practices be prevented.</p><ul><li>Please <strong>use the CRediT system</strong> (see <a href="https://credit.niso.org/">here</a>) to describe the contributions of each author, as listed on the title page of the manuscript.</li><li><strong>Typical role description</strong>: First authorâs full name: role(s) (one or more roles using the CRediT system); second authorâs full name: role(s); etc. <strong>OR</strong>: Use a role as a grouping factor and put the names of corresponding authors after a colon. This is preferable for studies with multiple authors. Please consult the journalâs editor on using this option.</li><li>Manuscripts <strong>with a single author</strong> should also have the Author contributions section.</li><li>Always finalize your Author contributions section as follows: The author [<em>or All the authors</em>] approved the version of the manuscript to be published and agreed to be accountable for all aspects of the work, ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.</li></ul><p> </p><p><strong>Examples</strong></p><table><tbody><tr><td><p><strong>Author contributions</strong>: John M. Doe: conceptualization, investigation, data curation, writingâoriginal draft, writingâreview & editing; Disha Srivastava: data curation, writingâreview & editing; Juliette James: data curation, investigation, writingâreview & editing; Jane Doe: data curation, writingâoriginal draft, writingâreview & editing. All the authors approved the version of the manuscript to be published and agreed to be accountable for all aspects of the work, ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.</p></td></tr><tr><td><p><strong>Author contributions</strong>: Conceptualization: John M. Doe, Juliette James; investigation, data curation, writingâoriginal draft, writingâreview & editing: Juliette James, Disha Srivastava. All the authors approved the version of the manuscript to be published and agreed to be accountable for all aspects of the work, ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.</p></td></tr><tr><td><p><strong>Author contributions:</strong> John M. Doe: conceptualization, investigation, writingâoriginal draft, writingâreview & editing.</p></td></tr></tbody></table><p> </p></details></div><div><details><summary><small>2) Acknowledgments</small></summary><p>Assistance in the investigation and dissemination of results is <em>insufficient </em>for the recognition of authorship (more information on the authorship criteria <a href="https://eco-vector.com/en/Eco-Vector_Ethic_Policy.php#12">here</a>). However, acknowledgment of assistance is an important aspect of academic integrity. By acknowledging other study contributors, you demonstrate respect for their efforts. This approach fosters sustainable professional relationships, accurately defines your contribution, and ultimately strengthens public trust in you and your work. Acknowledgements <em>may not be made</em> to anonymous individuals or <em>institutions </em>(some exclusions are possible).</p><p>Key considerations:</p><ul><li>Non-author contributions must be specified, preferably using the CRediT system (<a href="https://credit.niso.org/">https://credit.niso.org/</a>), but may be presented in free form.</li><li>The authors must ensure that the acknowledged individuals have agreed to be mentioned. Specify that the individuals mentioned do not object to being acknowledged at the end of this paragraph. <em>This information is not published</em>. For a group of individuals, be sure to receive the consent from their representative.</li><li>Acknowledging professional writing support in manuscript preparation, review, and editing is mandatory. Consent from professional writers is <em>not required</em>.</li><li>If you have no one to express your gratitude, please specify â<em>Not applicable</em>.â In that case, this statement <em>will be removed from the article upon publication.</em></li></ul><p> </p><p><strong>Examples</strong></p><table><tbody><tr><td><p><strong>Acknowledgments:</strong> The authors express their gratitude to faculty members and employees⦠[<em>the short official name of the organization</em> (<em>country</em>)], specifically Associate Professor⦠[<em>initials and surname</em>] for histological analysis, and Junior Research Associate... [<em>initials and surname</em>] for statistical analysis, and to Professor [<em>initials and surname</em>] (<em>the short official name of the organization</em>, <em>country</em>) for critical review and assistance in manuscript preparation.</p><p>[<em>Initials and surname</em>], [<em>initials and surname</em>], and [<em>initials and surname</em>] do not object to being mentioned by name. [<em>This part will not be published.</em>]</p></td></tr></tbody></table><p> </p></details></div><div><details><summary><small>3) Ethics approval</small></summary><p>The study authors have ethical obligations to society arising from their use of public resources (financial and n
582on-financial), potential social consequences of their work, the high risk of violating the rights and interests of study participants, inhumane treatment of animals, and mitigation of the potentially negative environmental impact of their study. Given that ethical obligations vary on a case-by-case basis, please describe the actions you took to comply with the generally accepted standards of academic ethics and explain any deviations from these standards.</p><ul><li>Report the following:</li><ul><li><strong>1) The result of the study protocol approval</strong> by an ethics committee or another competent authority with similar functions received prior to the study;</li><li><strong>2) Obtaining an informed consent</strong> to participate in the study, as well as to use the materials and/or data from participants (more details <a href="https://eco-vector.com/Eco-Vector_Ethic_Policy.php#5">here</a> and <a href="https://eco-vector.com/Eco-Vector_Ethic_Policy.php#6">here</a>);</li><li><strong>3) Registration of the study </strong>(and its protocol).</li></ul><li>Any <em>refusal </em>to perform the specified actions must be <em>documented</em>. If no ethics approval statement or informed consent have been obtained, the reasons must be <em>explained</em>.</li><li>If you have an ethics approval statement, <strong>please provide information</strong> about the committeeâs opinion (e.g., âthe study protocol was approved,â âthe request for ethics approval was rejected,â). <strong>Specify the type of ethics committee</strong> (e.g., independent, local, or other expert authority), its <strong>affiliation</strong>, the <strong>minutes number </strong>and the <strong>date of signing</strong>. <strong>The editorial staff may request an electronic copy of the statement, as well as the contact information of the representative of the ethics committee</strong>.</li><li>When obtaining informed consent, please specify whether the consent is <strong>written or verbal</strong>; the <strong>purpose</strong>, such as the use and/or dissemination of materials for research purposes, study participation, etc.</li><li>For a registered study, specify the <strong>place of registration</strong> (platform, database, journal, preprint repository, etc.), registration message <strong>identifier </strong>(URL, digital identifier, bibliographic record, etc.), and <strong>initial publication date</strong> of the message.</li></ul><p> </p><p>Authors may seek further clarification from the local ethics committee at their employing organization or from an independent ethics committee that reviews study protocols involving human participants, including studies using human materials and data.</p><p> </p><table><tbody><tr><td><p><strong>PLEASE NOTE:</strong></p><ol><li>Authors cannot exempt themselves or their study from having their study protocol reviewed by the ethics committee <strong>before the study initiation</strong>. Only an ethics committee may decide whether an ethical approval is required.</li><li>The requirement for ethical approval is independent of the study design. Medical research protocols involving human participants, <strong>including </strong>studies of [identifiable (per the <a href="https://www.wma.net/policies-post/wma-declaration-of-helsinki/">Declaration of Helsinki</a>, 2024) or non-identifiable (per the WHO-endorsed <a href="https://cioms.ch/publications/product/russian-translation-2016-international-ethical-guidelines-health-related-research-involving-humans/">CIOMS </a>International Ethical Guidelines for Health-related Research Involving Humans, 2016)] human materials and data, <strong>must be approved by an ethics committee</strong>. The status of materials and data as ânon-identifiableâ (which is not equivalent to âanonymizedâ) must also be confirmed by an ethics committee.<br> â Declaration of Helsinki, Paragraph 1: <em>The World Medical Association (WMA) has developed the Declaration of Helsinki as a statement of ethical principles for medical research involving human participants, including research using identifiable human material and data. ...23. The protocol must be submitted for consideration, comment, guidance, and approval to the concerned research ethics committee before the research begins.
582<br></em> â <a href="https://cioms.ch/publications/product/russian-translation-2016-international-ethical-guidelines-health-related-research-involving-humans/">CIOMS </a>Guideline 12: âThe protocol for <em>every </em>study <em>using collected data</em> must be submitted to a research ethics committeeâ¦â</li><li>According to Paragraph 36 of the Declaration of Helsinki:</li></ol><p><em>â...Reports of research not in accordance with the principles of this Declaration <strong>should not be accepted </strong>for publication.â</em></p><p>Please note that since 2002, the Russian Professional Medical Association (known as the National Medical Chamber since 2018) has been a collective member of the World Medical Association, whose General Assembly adopts updates to the Declaration (the most recent being in <a href="https://doi.org/10.24075/medet.2025.002">2024</a>).</p></td></tr></tbody></table><p> </p><p><strong>Examples</strong></p><table><tbody><tr><td><p><strong>Ethics approval:</strong> The study protocol was not reviewed by an ethics committee. No informed consent for participation in the study was obtained. Reason: the study used public data, which does not contain any personally identifiable information about patients. The study was registered at [<em>name of the institution with the URL for study registration message</em>] on [<em>initial publication date of the message in Month dd, yyyy format</em>].</p></td></tr><tr><td><p><strong>Ethics approval:</strong> The Independent Ethics Committee of [<em>official name of the institution where the committee operates</em>] rejected the request for an expert review of the study protocol (Minutes No. ... dated [<em>Month dd, yyyy</em>]). Reason: [<em>excerpt from the statement</em>]. All participants provided written informed consent. The study and the its protocol were not registered.</p></td></tr><tr><td><p><strong>Ethics approval:</strong> The study was approved by the Independent Ethics Committee of [<em>official name of the institution where the committee operates</em>] (Minutes No. ... dated [<em>Month dd, yyyy</em>]). All participants provided written informed consent to participate in the study including the use of study data. The study protocol is available at [<em>URL of the protocol</em>], published on [<em>Month dd, yyyy</em>].</p></td></tr><tr><td><p><strong>Ethics approval:</strong> The study was approved by the Local Ethics Committee of [<em>official name of the institution where the committee operates</em>] (Minutes No. ... dated [<em>Month dd, yyyy</em>]). All participants provided written informed consent for the use of their clinical assessment and treatment data for research purposes on admission. The study protocol was published in the [journal reference]. The manuscript was submitted on... [<em>Month dd, yyyy</em>].</p></td></tr></tbody></table><p> </p><p> </p></details></div><div><details><summary><small>4) Consent for publication</small></summary><p>Each manuscript that contains confidential information of an individual (<em>personal data</em>, photographs, <em>protected health information</em>, <em>or any other facts, events, and circumstances</em> of the individualâs personal or professional life), must include a statement on obtaining their informed consent <strong>for publication (!)</strong> of these data in a journal, including its online version. Personal data of children (individuals aged 0â17 years) can <strong>only be published with the permission of their legal representative.</strong></p><p>Publication of confidential data of an individual after their death also requires consent of legal representatives. One exception (determined by the importance of provided information) is when legal representatives or immediate family members cannot be located despite reasonable efforts of the authors. In such cases, describe the actions taken to locate legal representatives or immediate family members of the deceased individual.</p><p>In cases where informed consent for publication of confidential data <strong>was not obtained</strong>, specify the reason. <em>This information is published.</em></p><p>In the <em>Ethics Approval </em>section, specify whether informed consent for <strong>participation in the study (!)</strong> and/or the use of materials and data for research purposes was obtained from participants.</p><p>If you have obtained informed consent for publication, please provide the following information:</p><ul><li><strong>Consent form</strong> (verbal or written), <strong>signer </strong>(patient, legal representative, or other person), and <strong>signing date</strong>.</li><li>The authors must confirm that the <strong>scope </strong>of published confidential data has been <strong>agreed </strong>upon with the patient and/or their legal representative. <em>This information is published.</em> Insignificant personal information must be removed from the manuscript, even if the authors have obtained informed consent for publication of confidential data.</li></ul><p> </p><p><strong>Examples</strong></p><table><tbody><tr><td><p><strong>Consent for publication:</strong> Written informed consent was obtained from the patients [<em>and/or their legal representatives</em>] for the publication of their confidential data, including photographs [with faces obscured], in a scientific journal and its online version (signed on December 25, 2023). The scope of the published data was approved by the patient [<em>and/or their legal representative</em>].</p></td></tr><tr><td><p><strong>Consent for publication:</strong> No informed consent was obtained from the patient for publication of information on their health status during hospital
582ization. Reason: the patient was lost to follow-up (the telephone number specified in the medical record was blocked; the e-mail address was unknown; and contact information of the patientâs family members was unavailable). All data presented are anonymized, and no photographs are published.</p></td></tr></tbody></table><p> </p></details></div><div><details><summary><small>5) Funding sources</small></summary><p>The mandatory declaration of funding sources, including the preparation and publication of results reports, is important for several reasons: to inform readers about sponsors, maintain records necessary for controlling the expenditure of allocated research funds, and analyze the effectiveness of funding institutions for science in general and specific research programs. <strong>Funding sources may include</strong> for-profit or not-for-profit organizations, individuals or groups of individuals, state funds, and the authorâs affiliated institution (internal targeted funding, excluding salaries and costs of research covered under standard job duties).</p><p>Provide the following information:</p><ul><li>Please disclose the sources of funding for your research (!), <em>regardless of time when the relevant support was provided.</em> If the funding source is an institution, please specify its country of residence.</li><li>If funded, please indicate <strong>the form of support</strong> provided (<em>options</em>: direct (monetary) funding, indirect support, including the provision of tangible assets [consumables such as drug products, reagents, commercial kits, etc.]; fixed assets [equipment, software, etc.]; intangible assets [intellectual property, permits, etc.]; or services [logistics, consulting, training, and other third-party services]; laboratory animals, cell lines, etc.). <strong>A digital or another permanent identifier </strong>is typically specified for grants or contracts.</li><li>Describe the <strong>role of the funding source</strong> (<em>options</em>: conceptualization and design; control of inclusion criteria; enrollment; evaluation of study endpoints and registration of outcomes; data collection and verification; data analysis, interpretation, and management; data storage; formation of study team, management or other structures for study monitoring, oversight, and auditing; study management; logistics support; manuscript preparation, revision, and editing; manuscript approval; decision to submit the manuscript for publication; other [<em>specify</em>]). <em>Specify </em>if the source you mention <strong>was not involved</strong> in the study organization, planning, execution, or supervision; data collection, storage, analysis, or interpretation; manuscript preparation, making the decision to submit it for publication.</li><li>Disclose any <strong>restrictions </strong>that the funding source has imposed on data utilization or the dissemination of study findings, or<strong> absence thereof</strong>.</li><li>If the study had no funding sources, specify âNo funding.â</li></ul><p> </p><p><strong>Examples</strong></p><table><tbody><tr><td><p><strong>Funding sources:</strong> No funding.</p></td></tr><tr><td><p><strong>Funding sources: </strong>The study was funded by [<em>name of the funding organization</em>] (<em>country</em>) (Grant No. â¦); reagents were provided by [<em>name of the organization</em>] (<em>country</em>). The company was not involved in the study organization, planning, execution, or supervision; data collection, storage, analysis, or interpretation; manuscript preparation, making the decision to submit it for publication. The funding organizations imposed no restrictions on data utilization or the dissemination of study findings.</p></td></tr><tr><td><p><strong>Funding sources:</strong> This review was prepared and published (with a submission fee) using funds from a research grant received from [<em>name of the institution</em>] (<em>country</em>). [<em>The institution</em>] was not involved in the study organization, planning, execution, or supervision; data collection, storage, analysis, or interpretation; manuscript preparation, making the decision to submit it for publication. The authors have full access to all search and review findings.</p></td></tr></tbody></table><p> </p></details></div><div><details><summary><small>6) Disclosure of interests</small></summary><p>Any funding of the <strong>submitted research work</strong> (direct or indirect research funding, including publication of the results) must be specified in the <em>Funding Sources</em> section.</p><p>In the Disclosure of Interests section, the authors declare that they have or have no relationships with any stakeholders (for-profit or not-for-profit third parties, physical individuals) <strong>whose interests may be affected by the content of the article</strong>. To maintain transparency and trust in the research process:</p><ul><li>Declare that you have or have no relationships, activities, or interests for the last three years, <strong>specifying the stakeholder and form of relationships, activities, or interests</strong>;</li><li><strong>Possible options:</strong></li><ul><li><em>Primarily financial </em>(grants or contracts from any institution; authorâs fees or licenses; consulting fees; honoraria for lectures, presentations, public speaking arrangements; manuscript preparation or educational events; expert speaking fees; participation in meetings or travel expenses [business trips, etc.];
582 planned, issued, or pending patents; stocks or stock options; gifts), including resource allocation (equipment, materials, drug products, medical publications, other services);</li><li><em>Primarily non-financial</em> (participation in unpaid activities on behalf of third parties; personal or professional interest in a particular activity or in obtaining a specific result; political or religious preferences; other).</li></ul><li>Disclose not only <em>direct </em>relationships with third parties (e.g., receiving funds for purposes <em>unrelated </em>to this study), but also relationships<em> through your affiliated institution</em>.</li></ul><p>The authors may use the <a href="https://www.equator-network.org/reporting-guidelines/icmje-uniform-format-for-disclosure-of-competing-interests-in-icmje-journals/">Uniform Format for Disclosure of Competing Interests in ICMJE Journals</a> by the International Committee of Medical Journal Editors (ICMJE).</p><p> </p><p><strong>Examples</strong></p><table><tbody><tr><td><p><strong>Disclosure of interests:</strong> The authors have no relationships, activities, or interests for the last three years related to for-profit or not-for-profit third parties whose interests may be affected by the content of the article.</p></td></tr><tr><td><p><strong>Disclosure of interests:</strong> Initials and surname [<em>one of the authors</em>]: research grant from [<em>name of the institution</em>] (<em>country</em>), education and consulting fees from [<em>name of the institution</em>] (<em>country</em>); initials and surname [<em>one of the authors</em>]: conference management for [<em>name of the institution</em>] (<em>country</em>). Other authors have no relationships, activities, or interests for the last three years related to third parties whose interests may be affected by the content of the article.</p></td></tr></tbody></table><p> </p></details></div><div><details><summary><small>7) Statement of originality</small></summary><p>The <strong>failure to disclose</strong> the reuse of previously obtained (collected or created for a purpose other than that of the present work) and published <strong>first- or third-party </strong>information (data, code, text, tables, and images residing on physical or electronic media, on the Internet, and potentially accessible to an unlimited number of persons) <strong>constitutes an unacceptable research practice.</strong></p><ul><li>To avoid suspicion of research misconduct, <strong>please disclose any reuse of </strong>previously obtained and published information in the article, or<strong> emphasize the originality</strong> of the current work (<em>e.g.,</em> using data collected or created for the first time).</li><li>When using previously obtained or published material, specify the <strong>scope </strong>(in full or in part), authorship (first-party or third-party), <strong>format </strong>(text, images, or data), <strong>authorship and</strong> <strong>source </strong>(with a citation of the latter; for data citation, see <a href="https://doi.org/10.25490/a97f-egyk">here</a>), and <strong>copyright holderâs terms of use and distribution</strong> (copyright permission, license agreement, public domain, or other).</li></ul><p> </p><p><strong>Examples</strong></p><table><tbody><tr><td><p><strong>Statement of originality</strong>: No previously obtained or published material (text, images, or data) was used in this study or article.</p></td></tr><tr><td><p><strong>Statement of originality:</strong> This article contains extracts from our previously published work ([<em>bibliographic record or DOI</em>], distributed under the license <em>CC-BY 4.0</em>).</p></td></tr><tr><td><p><strong>Statement of originality:</strong> This work used first-party data for the control group (in full), an MRI image (Fig. 2) that was used in our previously published work ([<em>bibliographic record or DOI</em>], distributed with the copyright holderâs permission). Additionally, the Background section used text from [<em>specify</em> <em>initials and surname</em>] PhD thesis.</p></td></tr><tr><td><p><strong>Statement of originality:</strong> This work used an image (pathogenesis of the disease, Fig. 1) adopted from... [<em>Surname</em>] et al. [<em>reference</em>] (distributed under the license <em>CC-BY 4.0</em>).</p></td></tr></tbody></table><p> </p></details></div><div><details><summary><small>8) Data availability statement</small></summary><p>Data refers to any information used (<em>third-party data</em>) or obtained (<em>collected or created</em>) in a study. The authors must report the use of previously published first- or third-party data in the <em>Methods </em>section or other section appropriate for describing the research methodology, as well as in the <em>Statement of originality</em> section. Specify whether the article and/or its supplements present all the data obtained in the study (typical for review papers and case reports). In such cases, the editorial policy of the journal regulates data availability (access to the full text of the article and supplements).</p><p>If the article or its supplements do not present any dataset including images, text, code, etc., the following options are possible:</p><ul><li><strong>Data not available</strong>: This statement must be justified, indicating why the data are not available: due to confidentiality, safety issues, ethical, legal, and/or commercial limitations of data sharing.</li><li><strong>Data subject to restrictions:</strong> The<em> reasons and nature of restrictions </em>must be specified (on request, embargo, other [<em>specify</em>]). If the on-request restriction is used, the following must be <em>specified</em>: the form of request (free-form rationale or a request that includes, for example, the planned study protocol, ethics committee approval, statistical analysis plan, signed data use agreement, etc.), <em>contact person</em> (author or representative of the sponsor or another copyright holder), and <em>scope of data</em> that will be made available. If the embargo restriction is lifted, the <em>time </em>until the embargo is lifted must be specified.</li><li><strong>Data openly available in a public repository:</strong> In this case, provide access details, including the data location or <em>source name</em> (e.g., repository or other), the <em>link </em>(<em>or</em> bibliographic reference, URL, or persistent digital identifier of the data location), and <em>the terms of data distribution</em> (e.g., type of open license).</li></ul><p>Access to data from human studies (open or limited, full or partial), including studies of human biological materials and data, <strong>requires</strong> the <strong>permission</strong> <strong>of</strong> <strong>individuals</strong> (except for anonymized data, which cannot be identified even with additional information) and their legal representatives (in some cases, including after the participantâs death), and <strong>ethics committee approval</strong>. The authors must report compliance with this condition in the <em>Ethics Approval</em> section.</p><p>For more information on data citation (whether previously published first- or third-party data or generated or collected in the present study), see <a href="https://journals.eco-vector.com/index/pages/view/references_split">here</a>.</p><p> </p><p><strong>Examples</strong></p><table><tbody><tr><td><p><strong>Data availability statement:</strong> All data obtained in this study are available in the article.</p></td></tr><tr><td><p><strong>Data availability statement:</strong> All data obtained in this study are available in the article and its supplementary material. In particular, Supplement 1â¦</p></td></tr><tr><td><p><strong>Data availability statement: </strong>The data obtained in this study cannot be made publicly available for confidentiality reasons (the database contains personally identifiable information of study participants, and the participants did not consent to dissemination of this information or private health information).</p></td></tr><tr><td><p><strong>Data availability statement:</strong> The data obtained in this study cannot be made publicly available subject to a contract with the copyright holder (study sponsor) [<em>
582name</em>, <em>country</em>]. By agreement with the copyright holder, the study data will be available 12 months after publication of this article upon reasonable request (a brief description of the planned study protocol is mandatory).</p></td></tr></tbody></table><p> </p></details></div><div><details><summary><small>9) Generative AI</small></summary><p>Artificial intelligence (AI) is a set of technological solutions that imitate human cognitive functions. This set includes information and communication infrastructure, software (including those that use machine learning methods), and processes and services for data processing and search for solutions. AI technologies encompass computer vision, natural language processing, speech recognition and synthesis, and intelligent decision support. The authors must describe any use of AI for research purposes (study planning and conduct, data collection and analysis, statistical analysis) in the <em>Methods </em>section.</p><p>This section must contain the following:</p><ul><li>The authors must specify <strong>whether they used</strong> generative AI to <strong>prepare</strong> the manuscript, its parts (including images), or other submitted materials;</li><li>If AI is used for these purposes, the authors must specify the <strong>technology </strong>(<em>or</em> large language models, chatbots), <strong>purpose of use</strong> (to prepare the manuscript, its parts [<em>specify</em>], images, etc.), <strong>tool </strong>(software, platform, or service, indicating the URL as applicable), <strong>version</strong>, <strong>developer </strong>(country), and <strong>time of use</strong> (up to the month).</li></ul><p> </p><table><tbody><tr><td><p><strong>PLEASE NOTE:</strong> The authors must not list AI as an author or co-author, refer to AI as an author, or cite AI as an author (when using AI-generated texts or images. For more information on the journalâs editorial policy regarding the use of AI, see <a href="https://eco-vector.com/en/for_authors.php#031">here</a>.</p></td></tr></tbody></table><p> </p><p><strong>Examples</strong></p><table><tbody><tr><td><p><strong>Generative AI:</strong> No generative artificial intelligence technologies were used to prepare this article.</p></td></tr><tr><td><p><strong>Generative AI:</strong> This article [<em>or</em> article (in full or in part), authorâs abstract, images, tables, etc.] was prepared using [<em>tool</em>], version [<em>version number</em>] (<em>developer</em>, <em>https://...</em>). The chatbot was used from March to April 2024.</p></td></tr></tbody></table><p> </p></details></div><div><details><summary><small>10) Provenance and peer-review</small></summary><p>Articles published in the journal may be submitted unsolicited or commissioned by the journal; be reviewed following the fast-track or standard procedure; and be peer-reviewed by independent experts and other stakeholders, including those associated with the Editorial Office. To ensure transparency and properly inform readers, please disclose the <strong>origin of the manuscript</strong> upon submission (whether it is an unsolicited submission or was commissioned by the editors/editorial board).</p><p><strong> </strong></p><p><strong>Examples</strong></p><table><tbody><tr><td><p><strong>Provenance and peer-review:</strong> This article was submitted unsolicited.</p></td></tr><tr><td><p><strong>Provenance and peer-review:</strong> This article was commissioned by the Editorial Office.</p></td></tr></tbody></table><p> </p></details></div><div><details><summary><small>11) Disclaimer</small></summary><p>A disclaimer may be issued by the authors or their affiliated or otherwise associated institutions regarding any potential consequences arising from the publication of the article. <strong>This section will only be published at the authorsâ request.</strong></p><p> </p><p><strong>Examples</strong></p><table><tbody><tr><td><p><strong>Disclaimer.</strong> The authors declare that the views expressed in this article are solely their own and do not necessarily reflect the official positions of their affiliated
582institutions [<em>or</em> the study sponsor, or any other stakeholder].</p></td></tr><tr><td><p><strong>Disclaimer.</strong> The information presented in this article is intended for professionals only. The results and conclusions of this case study should not be considered as clinical guidelines. The authors are not liable for any misuse or application of the information contained herein.</p></td></tr></tbody></table></details></div><p> </p></div></details></div></div></details></div></p> 583 584<div class="separator"> </div> 585</div> 586 587 <div id="submissionPreparationChecklist"><h2>Submission Preparation Checklist</h2> 588 <p>As part of the submission process, authors are required to check off their submission's compliance with each of the following items, and submissions that do not adhere to these guidelines may be returned to the authors.</p> 589 <ul> 590 <li><p><strong>Absence of plagiarism</strong>. The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).</p></li> 591 <li><p><strong>Correct manuscript format</strong>
591. Manuscript file format is Microsoft Word (has the extension *.doc, *.docx, *.rtf). The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in "<a href="/index.php/clinicalpractice/about/submissions#authorGuidelines" target="_blank" rel="noopener noreferrer">For Authors</a>" section.</p></li> 592 <li><p><strong>Cover letter</strong>. All the required supporting documents will be submitted together with the manuscript. Authors guarantee to upload scanned original of the filled cover letter in PDF. A cover letter signed by all authors.</p></li> 593 </ul> 594 <div class="separator"> </div> 595 </div> 596<div id="copyrightNotice"> 597<h2>Copyright Notice</h2> 598<p><p>Authors who publish with this journal agree to the following terms:</p><ol><li>Authors transfer article copyright to the publisher only after the acceptance to publication.</li><li>Authors are able to use and distribute the article in accordance with Self-Archiving policy of the journal.</li><li>The article can be accepted for publication only by decision of the Editor-in-Chief and the Editorial board of the journal in accordance with the Manuscript selection policy of the journal.</li><li>Published Article will be distributed in print and electronic version and will be available under subscription with Delayed Open Access or in Immediate Open Access under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (<a href="https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ru" rel="noopener noreferrer">CC BY-NC-ND 4.0</a>). The access model depends on the publisher's decision or is determined by a separate Open Access publishing agreement with the authors.</li></ol><p>
598Other copyrights not directly transferred to the publisher under the License Agreement, including patent rights to any process, method etc., described by the Authors in the article, as well as trademark rights, are reserved for the Authors.</p><p>All the Copyright statements for authors are present in the standard Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical.</p><p>An exclusive license for publication granted by authors allows the publisher to use the article in the following ways:</p><ul><li>Reproduction of the Article or its sections or parts, as well as the metadata of the Article in any languages, in any material form, including on paper and electronic media, as a separate work in the journal and/or databases (local or in the Internet) of the publisher and/or other persons, at the discretion of the publisher;</li><li>Distribution of the Article or its sections or parts, as well as the metadata of the Article in any languages, on any medium as part of the journal and/or databases of the publisher or other persons, at the discretion of the publisher, or as an independent work around the world whether on Open-Access terms or for a fee without remuneration to the Author;</li><li>Making the Article or any of its sections or parts, as well as the Articleâs metadata in any languages, publicly available in such a way that any person can access the Article from any place, including via the Internet, and at any time of their own choosing;</li><li>Granting permission/s for the use of the Article or its sections or parts, as well as its metadata in any languages, to third parties with notice to the Author made by posting relevant information on the journalâs website, without paying remuneration to the Author;</li><li>Processing the Article (i.e., editing, correcting, annotating, tagging, translating to any languages, typesetting) and using the revised (translated) Article in the aforementioned ways.</li></ul><p>Other rights not directly transferred to the publisher under this License Agreement, including patent rights to any process, method etc., described by the Authors in the manuscript, as well as trademark rights, are reserved for the Authors.</p><p>All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical '<em>Journal of Clinical Practice'</em> .</p><div><details><summary><strong>READ the details online</strong> (tap to see in details)</summary><p><strong>Authorâs license agreement (public offer) on the publication of an article in a scholarly journal </strong><strong>'<em>Journal of Clinical Practice'</em></strong> </p><p>Eco-Vector, represented by its CEO Evgeniy Schepin and acting on the basis of the Charter (hereinafter referred to as the Publisher), on the one hand, offers an indefinite circle of persons (hereinafter referred to as the Author), and on the other hand, hereinafter jointly referred to as the Parties, to execute this agreement (hereinafter referred to as the Agreement) on the publication of scientific article (hereinafter referred to as the Article) in a scholarly journal '<em>Journal of Clinical Practice'</em> (further-the Journal) in accordance with the conditions stated below.</p><p> </p><p><strong>I. General Provisions</strong></p><ol><li>This Agreement, in accordance with clause 2 of Article 437 of the Civil Code of the Russian Federation, is a public offer (hereinafter referred to as the Offer) requiring full and unconditional acceptance (Acceptance), which, in accordance with Article 438 of the Civil Code of the Russian Federation, means the sending by the Author of his/her materials by way of uploading the same to the online electronic system designed to accept manuscripts for consideration, and subsequently posted in the corresponding section of the Journalâs website on the Internet information and telecommunications network (hereinafter referred to as the Internet).</li><li>In accordance with the current legislation of the Russian Federation regarding the observance of copyright on electronic information resources, all materials found in a website, including submitted and published in electronic journals, may not be reproduced in whole or in part in any form (electronic or printed) without the prior written permission of the Publisher. Prior permission can be given by publishing an article in the open access with Creative
598Commons license. The journal requires license users to reference the original source, i.e., the publication, if the Author permits use of the public materials in the context of other documents.</li></ol><p> </p><p><strong>II. Terms used in the Agreement</strong></p><ol><li>âAuthorâ refers to an individual (or individuals) whose creative work has led to the creation of the manuscript of a scientific Article, or to a representative of these persons.</li><li>âManuscriptâ is the result of intellectual activity in the form of a scientific work containing text, graphic and numerical data, audiovisual information, program code and other elements submitted by the Author for publication in the Journal; it is also the mean âa draft of an Article submitted by the Author to be published in the Journalâ.</li><li>âOfferâ is the current agreement (an offer to the author for the publication of an Article in the Journal).</li><li>âPublicationâ is the process of placement of an Article in the Journal.</li><li>âArticleâ is the manuscript that has been published in the Journal (after successful selection, editing, type-setting, copyediting, proofreading, translation).</li><li>âAcceptance of the offerâ refers to the full and unconditional acceptance of the offer on the terms specified in paragraph 3 of this agreement (the Author accepts offer by submitting a Manuscript to the Publisher via the online electronic submission system on the Journalâs Internet website).</li><li>âJournalâ is a scientific peer-reviewed periodical registered as a mass media entity in the Roskomnadzor register of the Russian Federation and ISSN-center.</li><li>âSubmissionâ is an electronic appeal of the Author to the Publisher for the publication of an Article in the Journal by uploading the manuscript and accompanying materials to the online electronic submission system on the Journalâs Internet website).</li><li>âPublisherâ refers to Eco-Vector, which is the Publisher of the journal.</li><li>Article metadata includes the information that are intended for inclusion in International Scientific Databases and search engines, namely the following:<br /> 599<ul><li>title of the Article;</li><li>information about each of the Authors (surname and first name; patronymic; place of work with the postal address indicated, contact information (e-mail));</li><li>abstract;</li><li>keywords;</li><li>thematic rubricator: UDC (Universal Decimal Classification) or other library and bibliographic classification and subject indexes;</li><li>list of references.</li></ul></li><li>âEditorial boardâ is the creative team that prepares the journal for publication.</li><li>âPartiesâ refers to the Author and the Publisher.</li><li>âAuthor Guidelinesâ are the requirements for Articles published in the Journal, posted in the âFor authorsâ section of the Journalâs Internet website.</li></ol><p> </p><p><strong>III. Subject of the Agreement (Offer)</strong></p><ol><li>Under this agreement, the Author grants the Publisher, free of charge for the entire period of validity in accordance with the legislation of the Russian Federation, an exclusive license to use the Article created by the former for publication in the Journal, as well as the rights to use the article in the following ways:<br /> 600<ul><li>Reproduction of the Article or its sections or parts, as well as the metadata of the Article in any languages, in any material form, including on paper and electronic media, as a separate work in Journals and/or databases (local or in the Internet) of the Publisher and/or other persons, at the discretion of the Publisher;</li><li>Distribution of the Article or its sections or parts, as well as the metadata of the Article in any languages, on any medium as part of the Journal and/or databases of the Publisher or other persons, at the discretion of the Publisher, or as an independent work around the world whether on Open-Access terms or for a fee without remuneration to the Author;</li><li>Making the Article or any of its sections or parts, as well as the Articleâs metadata in any languages, publicly available in such a way that any person can access the Article from any place, including via the Internet, and at any time of their own choosing;</li><li>Granting permission/s for the use of the Article or its sections or parts, as well as its metadata in any languages, to third parties with notice to the Author made by posting relevant information on the Journalâs website, without paying remuneration to the Author;</li><li>Processing the Article (i.e., editing, correcting, annotating, tagging, translating to any languages, typesetting) and using the revised (translated) Article in the aforementioned ways.</li></ul></li><li>Other rights not directly transferred to the Publisher under this Agreement, including patent rights to any process, method etc., described by the Author in the Article, as well as trademark rights, are reserved for the Author.</li><li>The territory where the rights to the Article are allowed to be used is the whole world.</li><li>The validity of this Agreement commences only if the manuscript of the Article is accepted for publication in the Journal and only from the moment of sending a notification of acceptance of the Article for publication to the Author from the official e-mail of the Journal.</li><li>The rights are granted by the Author to the Publisher free of charge; the publication of the Article in the Journal does not entail any financial deductions to the Author.</li><li>If the Publisher decides to reject the Submission or refuse to publish the Article in the Journal (i.e., retraction of the published Article), this Agreement becomes invalid. The decision to refuse publication will be sent to the Author at the e-mail address specified in the Submission.</li></ol><p> </p><p><strong>IV. Rights and Duties of the Parties</strong></p><ol><li>The Author guarantees that:<br /> 601<ul><li>s/he holds the copyright the exclusive rights to the materials submitted to the Publisher as part of the manuscript of the Article;</li><li>the rights granted to the Publisher under this agreement have not been previously transferred and will not be transferred to third parties in the future during the duration of the Agreement;</li><li>the manuscript contains all references to the cited authors and/or publications (materials) provided for under the current copyright legislation;</li><li>the Author has obtained all the necessary permissions for all information and other materials s/he holds no copyright to and that are used in the manuscript of the Article;</li><li>the Article manuscript contains only materials permitted to be published in the open press in accordance with the current legislative acts of the Russian Federation, and its publication and distribution will not lead to the disclosure of secret (confidential) information (including state secrets);</li><li>the Author has informed co-authors about the terms of this Agreement and has received their consent to execute this Agreement under the terms provided for in the Agreement.</li></ul></li><li>The Author carries certain obligations under the terms of the Agreement:<br /> 602<ul><li>s/he should prepare and submit the manuscript of the Article in accordance with the Author Guidelines posted on the Journalâs website;</li><li>the Author should not use an electronic copy of the Article for commercial purposes and in other journal publications without the consent of the Publisher;</li></ul></li><li>in the process of preparing a manuscript for publication, the Author is obligated to undertake the following:<br /> 603<ul><li>make corrections to the text of the manuscript that have been marked by the peer-reviewers and accepted by the editorial board, and/or as necessary, upon the request of the Publisher and the editorial board, finalize the manuscript of the Article;</li><li>revising and proofreading the manuscript of the Article in accordance with the editorial recommendations;</li><li>suggest only the minimum of corrections to the type-setted (layout) Article.</li></ul></li><li>The Author has the following rights and duties:<br /> 604<ul><li>Use preprint or prior-to publication versions of an unpublished Article in the form and content accepted by the Publisher for publication in the Journal. Such prior-to-publish versions can be placed as electronic files on the personal websites of the Author (co-authors) or on the protected external websites of the employers of the Author; however, the Author cannot use the unpublished version(s) for commercial sale or for systematic external distribution by a third party (i.e., post on social media). The author or co-authors must, in turn, carry out certain duties, namely:<br /> 605<ul><li>include the following warning in the prior-to-publish version: âThis is prior-to-publish version of the article accepted for publication in (Journalâs name), © Eco-Vector (year)â;</li><li>provide the corresponding electronic link to the Publisherâs website at <a href="https://journals.eco-vector.com/">https://journals.eco-vector.com/</a> and/or via the DOI.</li></ul></li><li>Copy or transfer a copy of the published Article in whole or in part to colleagues free of charge for their personal or professional use, for the promotion of academic or scientific research, or for informational purposes of the Authorâs employer.</li><li>Use materials from a published Article in a book written by one of the co-authors.</li><li>Use figures, tables and text excerpts from the Article for his or her (or co-authorsâ) own training purposes, or to include them in other published works in printed or electronic format by a third party, or to submit them in electronic format on an internal
605computer network, or on the public website of the Author (co-authors) or his/her employer.</li><li>Include the Article in educational collections for use in the classroom, either for free distribution to the Authorâs (co-authorsâ) students or in electronic format on a local server for access by students as part of the training course, as well as for internal training programs at the institution of the Authorâs employer.</li></ul></li><li>The Publisher, for its part, is obliged to:<br /> 606<ul><li>publish the Authorâs article in the Journal in printed and electronic form in accordance with the terms of this Agreement;</li><li>if necessary, as so decided by the Journalâs editorial board, provide the Author with the proofreading of the manuscript and make a reasonable editing;</li><li>provide to the Author the unlimited access to the final electronic version of the published Article (Version of Record) through the online electronic submission system on the Journalâs Internet website;</li><li>comply with the Authorâs rights as provided for by the current legislation, as well as protect them and take all necessary measures to prevent copyright infringement by third parties.</li></ul></li><li>The Publisher has a right to:<br /> 607<ul><li>conduct an expert evaluation of the manuscript (peer-reviewing and editorial evaluation) and invite the Author to make the necessary changes (revisions) to the manuscript;</li><li>provide editing, copyediting, type-setting, proofreading, tagging, indexation and translation of the Articleâs manuscript without altering the main content;</li><li>in any subsequent authorized use by the Author (and/or other persons) of the Journal and/or Article (including any separate part or fragment thereof), require that a link to the Journal, Publisher, Author or other copyright holders, the title of the Article, the Journalâs volume/issue, and the year of publication be specified in the Journal;</li><li>post preliminary and/or advertising information about the upcoming publication of the Article in the media and other information sources;</li><li>make changes to the offer in accordance with the procedure established by the offer.</li></ul></li><li>The editorial board of the Journal, headed by the editor-in-chief, has the exclusive rights to select and/or reject materials sent to the Journal editorial office for publications purposes. The manuscript sent by the Author to the Journal editorial office is not subject to return. The editorial board of the Journal does not enter into correspondence about rejection of submissions.</li><li>In all cases not stipulated and not provided for in this agreement, the parties are obliged to be guided by the relevant current laws of the Russian Federation.</li></ol><p> </p><p><strong>V. Acceptance of the Offer and Execution of the Agreement. Terms of the Agreement</strong></p><ol><li>The Author accepts the Offer by submitting the manuscript on the Article to the Publisher through the electronic manuscript submission system on the Journal's Internet website.</li><li>Acceptance of the offer by the author creates an Agreement in writing (Articles 438 and 1286.1 of the Civil Code of the Russian Federation) on the terms of the offer.</li><li>This Agreement is valid for the duration of the exclusive rights to the Article.</li><li>When transferring (alienating) the exclusive right to the Article by the Author to a third party, this Agreement does not terminate.</li></ol><p> </p><p><strong>VI. Procedure for changing and terminating the Agreement</strong></p><ol><li>The Publisher has the right to unilaterally change the terms of this Agreement, in advance, at least 10 (ten) calendar days before the entry into force of the intended relevant changes, but with notice to the Author through the Journalâs website or by e-mail to the Authorâs e-mail address specified in the Authorâs Submission. The changes will take effect from the date specified in the relevant notification.</li><li>If the Author rejects the changes to the terms of this Agreement, s/he has the right to notify the Publisher by sending a written notification through the online manuscripts submission system, making sure that the same is sent to the official e-mail address of the editorial office.</li><li>This Agreement may be terminated prematurely, either by agreement of the parties at any time, or on other grounds provided for in this Agreement.</li><li>The Author has the right to unilaterally withdraw from the execution of this Agreement by sending the Publisher a corresponding notification in writing at least 60 (sixty) calendar days in advance before the expected date of publication of the Article in the Journal.</li><li>Termination of the Agreement for any reason does not release the parties from liability for any violation of the terms of the Agreement that occurred during the validity period.</li></ol><p> </p><p><strong>VII. Responsibility</strong></p><ol><li>The parties are responsible for non-fulfillment or improper fulfillment of their obligations under the Agreement in accordance with the current relevant legislation of the Russian Federation.</li><li>All information provided by the Author must be reliable. The Author is expected to provide accurate and complete the information to the Publisher. When using false information received from the Author, the Publisher is not responsible for the negative consequences caused by his actions on the basis of the false information provided.
607</li><li>With regard to the content of the Article, the Author is solely responsible for compliance with the requirements of the laws of the Russian Federation pertaining to advertising, copyright and related rightsâ protection, protection of trademarks and service marks, and the protection of consumer rights.</li><li>The Publisher does not bear any responsibility under the agreement:<br /> 608<ul><li>for any actions that are a direct or indirect result of Authorâs illegal actions;</li><li>for any loss incurred by the Author, regardless of whether the Publisher could have foreseen the possibility of such losses or not.</li></ul></li><li>The Publisher is released from liability for violation of the terms of the Agreement if such violation is caused by force majeure, including actions of state authorities (including the adoption of legal acts), fire, flood, earthquake, other natural disasters, lack of electricity and/or computer network failures, strikes, civil unrest, riots, etc.</li></ol><p> </p><p><strong>VIII. Dispute resolution</strong></p><ol><li>Disputes and disagreements will be resolved by the parties through negotiations, and in case of failure to reach an Agreement they will strive to seek resolution in accordance with the current legislation of the Russian Federation.</li><li>If there are unresolved disagreements, the parties agree to resolve the disputes in court at the jurisdiction covered by the Publisherâs location in accordance with the current legislation of the Russian Federation.</li></ol><p> </p><p><strong>IX. Miscellaneous</strong></p><ol><li>All notifications, messages, requests, etc. (with the exception of documents that must be sent as originals in accordance with the laws of the Russian Federation) are considered received by the Author if they were transmitted (sent) by the Publisher through the Journalâs website (including by publication), fax, e-mail based on the address specified in the Submission, and other communication channels. The parties recognize the legal force of notifications, messages, requests, etc., transmitted (sent) by the above methods.</li><li>In the event of claims against the Publisher related to the violation of the exclusive copyright and other intellectual property rights of third parties when creating an article or in connection with the execution of this Agreement by the Author, as well as in connection with the use of the Article by the Publisher in accordance with the Agreement, the author undertakes:<br /> 609<ul><li>To immediately take measures to resolve disputes with third parties soon after receiving Publisherâs notification, and if necessary, enter into legal proceedings on the Publisherâs side and take all appropriate actions needed to exclude the Publisher from the list of defendants;</li><li>To reimburse the publisher for the legal costs incurred and expenses and losses caused by the application of measures to secure the claim and execute a court decision, and the money paid to a third party for the violation of exclusive copyright and other intellectual property rights, as well as other losses incurred by the Publisher in connection with the Authorâs non-compliance with the guarantees provided by them under this Agreement.</li></ul></li></ol><p> </p><p><strong>X. Legal address and details of the Publisher</strong></p><ul><li>Eco-Vector</li><li>Address: 191186, St. Petersburg, Aptekarsky Pereulok, 3 letter A, room 1N</li><li>TIN: 7806423692; KPP: 784101001; OGRN: 1099847039907.</li></ul></details></div></p> 610 611<div class="separator"> </div> 612</div> 613 614<div id="privacyStatement"> 615<h2>Privacy Statement</h2> 616<p><p>The editorial Board of the journal and the administration of the website of the journal do not transfer personal information in any way specified by the users when working with the website of the journal to third parties, except for those cases and to the extent specified in the terms of the copyright agreement.</p><p>The affiliation work and e-mail address of the authors of the manuscript accepted for publication will be published in the section "information about the authors" of the printed ver
616sion of the journal and in the section "about the authors" on the page of the article on the website of the journal.</p><p>The phone number of the corresponding author will be known only to the editorial Board Secretariat and will only be used in cases of emergency.</p></p> 617 618<div class="separator"> </div> 619</div> 620 621 622<div id="authorFees"> 623<h2>Author Fees</h2> 624 <h3>General information on paid services for authors</h3> 625<p>'<em>Journal of Clinical Practice</em>' do not levy any mandatory additional fees from authors (NO Article Processing Charge, NO Publishing Fees).</p> 626<p>Eco-Vector Publishing house offers authors a number of additional paid services DOES NOT AFFECT the peer-review results and the editorial board decisions:</p> 627<ul> 628<li>Fast-Track (emergency peer-review of the manuscript).</li> 629<li>Full-text translation from/into English and other languages. This option is only available for authors whose manuscript has been accepted for publication by the editorial board, and only after the appropriate notification from the editorial team.</li> 630</ul> 631<hr> 632 <p><h3>Fast-Track:</h3><b>Price: 1100.00 (USD)</b><br /> 633 <p><strong>Optional payment</strong></p><p>The Fast-Track protocol allows authors to request an extremely fast peer-review based evaluation of an article and to receive a final decision within 21 days.</p><p>For the Fast-Track users:</p><ul><li>the guaranteed final decision time is <strong>21 days</strong>, starting the count from the first business day on which valid payment information has been received from the submitting author; Authors will receive a report with peer-review results and a decision letter from the Editor-in-Chief and the Editorial Board;</li><li>in case of manuscript acceptance by Editor-in-Chief and Editorial Board members (in regards with positive peer-reviews) â the guaranteed publication is a nearest upcoming issue of the journal and Online First publication ASAP.<br><br></li></ul><p>More information about activating the Fast-Track protocol is available <a href="https://journals.eco-vector.com/index/pages/view/FT_option">here</a>.</p><hr><p> 634 <p><h2>Waiver policy</h2><p>An author's team can apply to the Editor-in-Chief for Publishing Fees cancellation or for a discount. We don't want the need for payment to become a barrier to publishing high-quality work in our journal.</p><p>To receive a discount, a member of the author team should submit a written collective request to the publisher for a discount on Publishing Fees, along with a justification for their request.</p><p>The decision on whether to grant a discount and its amount is made jointly by the editor-in-chief and the publisher's management based on the author's request. If the discount is approved, authors will be informed of the final cost and further payment instructions.</p><p>Discounts are available for all paid publishing services (Immediate Open Access Charge, Fast-Track protocol, Publishing Fees) as part of <a href="https://journals.eco-vector.com/index/pages/view/vip_reviewers" target="_blank" rel="noopener">the Peer-Reviewer Rewards Program</a>.</p></p> 635 </div> 636 637 <br /> 638 <div id="pageFooter"><hr> 639<div style="margin-top: 24px;"><img style="vertical-align: middle;" src="https://kazanmedjournal.ru/files/journals/10/misc/interface/16.gif" width="28" height="28"> <small style="font-size: 11px; color: gray;">СÐРзаÑегиÑÑÑиÑовано ФедеÑалÑной ÑлÑжбой по надзоÑÑ Ð² ÑÑеÑе ÑвÑзи, инÑоÑмаÑионнÑÑ ÑÐµÑ Ð½Ð¾Ð»Ð¾Ð³Ð¸Ð¹ и маÑÑовÑÑ ÐºÐ¾Ð¼Ð¼ÑникаÑий (РоÑкомнадзоÑ). <br></small><small style="font-size: 11px; color: gray;">РегиÑÑÑаÑионнÑй Ð½Ð¾Ð¼ÐµÑ Ð¸ даÑа пÑинÑÑÐ¸Ñ ÑеÑÐµÐ½Ð¸Ñ Ð¾ ÑегиÑÑÑаÑии СÐÐ: ÑеÑÐ¸Ñ <a href="https://rkn.gov.ru/mass-communications/reestr/media/?id=331011&page=" target="_blank" rel="noopener">ÐÐ â ФС 77 - 38032</a> Ð¾Ñ 11 ноÑбÑÑ 2009 года.</small></div></div> 640 641</div><!-- content --> 642</div><!-- main --> 643</div><!-- body --> 644 645 646 647</div><!-- container --> 648 649<footer> 650 <div class="separator"> </div> 651<div class="underFooter"> 652<div class="central"> 653<div> 654<p> </p> 655<p>Developed by <a href="https://eco-vector.com" target="_blank" rel="noopener">ECO-VECTOR</a></p> 656</div> 657<div> 658<p> </p> 659<p>Powered by <a href="https://new.fips.ru/registers-doc-view/fips_servlet?DB=EVM&DocNumber=2023614878" target="_blank" rel="noopener">EVESYST</a></p> 660</div> 661<div><img style="padding-top: 5px;" src="https://journals.eco-vector.com/img/style/18_plus_icon.png" alt="" width="50px" height="50px"></div> 662</div> 663</div> 664 </footer> 665 666 667 668 669 670 671<a href="#" class="scrollup">TOP</a>
672<script type="text/javascript"> 673 $(document).ready(function(){ 674 675 $(window).scroll(function(){ 676 if ($(this).scrollTop() > 100) { 677 $('.scrollup').fadeIn(); 678 } else { 679 $('.scrollup').fadeOut(); 680 } 681 }); 682 683 $('.scrollup').click(function(){ 684 $("html, body").animate({ scrollTop: 0 }, 600); 685 return false; 686 }); 687 688 }); 689</script>
689 690 691 692</body> 693</html>
Line numbers count LF bytes from the start of the resource, as the search results do. Vendor segments are library code the classifier recognised; they are stored but not indexed. Bytes are shown as Latin1 characters, one per byte.